MORIHITO OKADA

Last Updated :2026/06/03

Affiliations, Positions
Research Institute for Radiation Biology and Medicine, Professor
E-mail
morihito1217gmail.com

Basic Information

Academic Degrees

  • Doctor of Philosophy in Medical Science, Kobe University

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical surgery;Respiratory surgery

Research Keywords

  • Surgical oncology, Esophageal cancer, Lung cancer, Breast cancer, Mesothelioma, Surgery, Endoscopic surgery, Thoracosocopic surgery, Chemotherapy, Chemoradiotherapy, Immunotherapy, Oncogenes, Gene therapy, PET, Biomarker, Liquid biopsy

Educational Activity

Course in Charge

  1. 2026, Undergraduate Education, Year, Clinical diagnosis and treatment I
  2. 2026, Undergraduate Education, Year, Systemic Disease Control
  3. 2026, Undergraduate Education, Intensive, Practice for medical research
  4. 2026, Undergraduate Education, Intensive, Practice of Medicine I
  5. 2026, Undergraduate Education, Intensive, Practice of Medicine II
  6. 2026, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Surgical Oncology
  7. 2026, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Surgical Oncology
  8. 2026, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Surgical Oncology
  9. 2026, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Surgical Oncology
  10. 2026, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Breast Cancer Treatment
  11. 2026, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Breast Cancer Treatment
  12. 2026, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Surgical Oncology
  13. 2026, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Surgical Oncology

Research Activities

Academic Papers

  1. Correction: Thoracic and cardiovascular surgeries in Japan during 2020 : Annual report by the Japanese Association for Thoracic Surgery., Gen Thorac Cardiovasc Surg, 72(1), 61-94, 202502
  2. Effectiveness and safety of combination immunotherapy with or without ipilimumab according to PD-L1 expression in patients with non-small cell lung cancer: a multi-center retrospective cohort study., Transl Lung Cancer Res., 15(3), 59, 202603
  3. Prediction of Pathological Response and Prognosis After Surgery by Tumor Reduction During Neoadjuvant Chemotherapy in Patients With Esophageal Squamous Cell Carcinoma., Anticancer Res, 46(3), 1629-1638, 202603
  4. Induction chemotherapy plus bevacizumab or radiotherapy in N2 non-squamous non-small cell lung cancer: 5-year results of a randomized phase 2 trial., JTCVS Open, 30, 101607, 202602
  5. Prognostic Value of Metabolic Parameters on Dedicated Breast Positron Emission Tomography in Luminal Breast Cancer, Anticancer Res, 46(3), 1677-1684, 202603
  6. Differences of HER2 Status by HercepTest and PATHWAY 4B5 Immunohistochemical Assays in Breast Cancer, Anticancer Res, 46(2), 1123-1130, 202602
  7. Correction: Thoracic and cardiovascular surgeries in Japan during 2021 : Annual report by the Japanese Association for Thoracic Surgery, Gen Thorac Cardiovasc Surg, 73(2), 133-136, 202502
  8. Changes in chemotherapy-induced cognitive impairment in gastrointestinal cancer survivors using multidomain assessments: a prospective cohort study, J Cancer Surviv, 202502
  9. Reply to letter to the editor titled "Recurrence and prognostic predictors in pathologic T1N0 esophageal squamous cell carcinoma treated with surgery alone", Surgery, 183, 109386, 202507
  10. Reply to: "Should Muscle Mass be Incorporated into Surgical Decision Making for Early-Stage Lung Cancer?", by Yan et al., Ann Surg Oncol., 32(10), 7958, 202510
  11. CRES3T: A single- arm confirmatory trial of S-1 plus cisplatin with concurrent radical-dose radiotherapy followed by surgery for superior sulcus tumors., Lung Cancer, 202, 108506, 202504
  12. A Subgroup Analysis of Perioperative Pembrolizumab in Clinical Stage II Non-Small-Cell Lung Cancer from the Randomized KEYNOTE-671 Study, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 68(3), ezag028, 202603
  13. Determinants and Mechanisms of Postoperative Effort Intolerance in Suspected Lung Cancer ― An Exercise-Stress Echocardiography Study ―, CIRCULATION JOURNAL, 90(4), 376-387, 202604
  14. Atezolizumab Combined With Cisplatin Plus Vinorelbine as Adjuvant Therapy for Completely Resected NSCLC With EGFR Mutation (West Japan Oncology Group 11719L: ADJUST Study), JTO CLINICAL AND RESEARCH REPORTS, 7(5), 100967, 202602
  15. IMpower010: 5-Year Outcomes of Atezolizumab in Japanese Patients With Resected Stage IB-IIIA Non-Small Cell Lung Cancer, CANCER SCIENCE, 117(3), 749-758, 202603
  16. Perioperative Nivolumab in Resectable Non-Small Cell Lung Cancer: A Subanalysis of Japanese Patients From Checkmate 77T, CANCER SCIENCE, 117(3), 759-768, 202603
  17. Clinical Characteristics and Predictive Factors of Immune-Mediated Cholangitis: A Large Single-Center Retrospective Observational Study, CANCERS, 18(4), 685, 20260219
  18. Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer, JOURNAL OF CLINICAL ONCOLOGY, 44(7), 553-564, 20260301
  19. Plasminogen Activator Inhibitor-1 Mediates Tolerance to Anti-PD-1 Immunotherapy in Non-Small Cell Lung Cancer, MOLECULAR CANCER THERAPEUTICS, 25(3), 435-447, 20260302
  20. Merlin Immunohistochemistry Is Useful in the Differential Diagnosis of Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia, PATHOLOGY INTERNATIONAL, 76(1), e70069, 202601
  21. Prognosis, imaging characteristics, and clinicopathological features of heavy smokers with clinical stage I lung adenocarcinoma: a multicenter study, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 74(1), 65-72, 202601
  22. A preoperative risk scoring system for survival prediction in clinical stage IB lung adenocarcinoma: a multicenter study, FRONTIERS IN ONCOLOGY, 15, 1712276, 20260106
  23. Development and validation of a nomogram incorporating YpT stage for predicting ypN0 using multicenter data in clinically node-positive breast cancer, SCIENTIFIC REPORTS, 16(1), 2344, 20251210
  24. Prognostic Impact of Ground-Glass Opacity in Clinical Stage IA Non-Small Cell Lung Cancer With Interstitial Lung Abnormalities, INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY, 40(11), ivaf260, 202511
  25. Serum IgG titer findings for Fusobacterium nucleatum associated with clinical outcome following surgery in patients with esophageal squamous cell carcinoma, PLOS ONE, 20(11), e0336219, 20251121
  26. Loco-regional Recurrence After Segmentectomy for Peripheral and Radiologically Solid-dominant Tumours, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 67(12), 202512
  27. Recurrence Risk Stratification by Station- and Zone-Based Nodal Classification in Resected Non-Small Cell Lung Cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 67(10), 202510
  28. Lobectomy Induces Exercise-Induced Pulmonary Hypertension and Effort Intolerance Compared With Sublobar Resection, JTO CLINICAL AND RESEARCH REPORTS, 6(11), 100903, 202509
  29. Visceral Pleural Invasion as a Determinant of Surgical Strategy in Non-Small Cell Lung Cancer: A Multicenter Study, CANCERS, 17(20), 3382, 20251020
  30. Treatment outcomes of esophageal squamous cell carcinoma with cM1 lymph node without organ metastasis, DISEASES OF THE ESOPHAGUS, 38(5), doaf095, 202509
  31. Lymph node dissection as a local control during segmentectomy for small-sized and radiologically solid dominant and pure solid tumors, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 55(11), 1286-1291, 202511
  32. Treatment Outcomes and Significance of Multimodal Treatment in Esophageal Squamous Cell Carcinoma with Synchronous Oligometastasis, CANCERS, 17(21), 3407, 20251023
  33. Prognostic Impact of Cardiovascular Injuries for Patients with Respiratory Isolated Chest Trauma, INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY, 40(11), 202511
  34. Trends in isolated chest trauma in Japan: a 15-year analysis using the Japan Trauma Data Bank, JOURNAL OF THORACIC DISEASE, 17(8), 20250831
  35. Dynamic changes of blood glucose level during capivasertib treatment in metastatic breast cancer: a case report, DIABETOLOGY INTERNATIONAL, 16(4), 851-854, 20250806
  36. Relationship between walking distance within the first 24 h following lung cancer surgery and clinical outcomes, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 73(9), 709-717, 202509
  37. Neoadjuvant Concurrent Chemo-Immuno-Radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage III N2 NSCLC : Primary Results From the SQUAT Trial (WJOG 12119L), JOURNAL OF THORACIC ONCOLOGY, 20(8), 1098-1107, 202508
  38. Quality comparison of mediastinal lymph node dissection between video-assisted thoracic surgery and open thoracotomy: a supplementary analysis of the phase 3 Japan Clinical Oncology Group 1413 trial†, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 67(7), 202507
  39. Impact of pectoralis major muscle mass decrease after lobectomy on the prognosis of lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 55(8), 941-946, 202508
  40. Prognostic value of FDG PET/CT in special types of breast cancer with non-favorable histology, DISCOVER ONCOLOGY, 16(1), 20250731
  41. Segmentectomy versus lobectomy for centrally located small-sized and radiologically pure-solid non-small cell lung cancer, JTCVS OPEN, 25, 415-423, 202504
  42. Prognostic Benefit of Segmentectomy for Patients with Low Muscle Mass in Early-Stage Lung Cancer, ANNALS OF SURGICAL ONCOLOGY, 32(7), 4660-4669, 202507
  43. Longitudinal assessment of functional independence of older adults after lung cancer surgery: Final results of the JCOG1710A prospective cohort study, JOURNAL OF GERIATRIC ONCOLOGY, 16(6), 202507
  44. Thoracic and cardiovascular surgeries in Japan during 2023, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 73(7), 526-565, 202507
  45. Dual inhibition of GTP-bound KRAS and mTOR in lung adenocarcinoma and squamous cell carcinoma harboring KRAS G12C, CELL COMMUNICATION AND SIGNALING, 23(1), 20250511
  46. Diversity of ER-positive and HER2-negative breast cancer stem cells attained using selective culture techniques, SCIENTIFIC REPORTS, 15(1), 20250310
  47. Segmentectomy versus lobectomy in younger patients with early-stage non-small cell lung cancer, INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY, 40(2), 20250303
  48. Role of guanylate-binding protein 1 in the proliferation of invasive lung adenocarcinoma cells, FRONTIERS IN ONCOLOGY, 15, 20250213
  49. Evaluating the risk of underdiagnosis of invasive breast cancer in needle biopsy-diagnosed ductal carcinoma in situ eligible for radiofrequency ablation, WORLD JOURNAL OF SURGICAL ONCOLOGY, 23(1), 43, 20250205
  50. Exploring the possibility of omitting axillary surgery in patients with clinical node-positive breast cancer achieving ypT0 after neoadjuvant chemotherapy, BREAST CANCER RESEARCH AND TREATMENT, 212(1), 47-56, 202507
  51. Mediastinal lymph node dissection in segmentectomy for peripheral c-stage IA (≤2 cm) non-small-cell lung cancer, J Thorac Cardiovasc Surg, 169(4), 1108-1119.e3, 202504
  52. Comparative oncological features of centrally and peripherally located small-sized radiologically solid-dominant non-small-cell lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 67(4), ezaf072, 202503
  53. Role of 18F-fluorodeoxyglucose accumulation in radiological ground-glass opacity of non-small cell lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 55(4), 391-398, 202504
  54. Thoracic and cardiovascular surgeries in Japan during 2022 Annual report by the Japanese Association for Thoracic Surgery, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 73(4), 254-294, 202504
  55. Risk Factors for Locoregional Relapse After Segmentectomy: Supplementary Analysis of the JCOG0802/WJOG4607L Trial, JOURNAL OF THORACIC ONCOLOGY, 20(2), 157-166, 202502
  56. Feasibility and comparative prognosis of segmentectomy versus lobectomy in centrally located small and solid dominant cN0 non-small cell lung cancer, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 169(2), 427-435.e2, 202502
  57. Recurrence and prognostic predictors in pathologic T1N0 esophageal squamous cell carcinoma treated with surgery alone, SURGERY, 178, 202502
  58. ASO Author Reflections: Surgical Procedures for Early-Stage Lung Cancer Patients with Low Muscle Mass, Ann Surg Oncol, 32(6), 4191-4192, 202507
  59. Prediction of Pathologic Complete Response in Esophageal Squamous Cell Carcinoma Using Preoperative Serum Small Ribonucleic Acid Obtained After Neoadjuvant Chemoradiotherapy, ANNALS OF SURGICAL ONCOLOGY, 32(1), 570-580, 202501
  60. Omitting Lymph Node Dissection for Small Ground-Glass Opacity-Dominant Tumors, ANNALS OF THORACIC SURGERY, 119(1), 192-198, 202501
  61. Atezolizumab and Platinum Plus Pemetrexed With or Without Bevacizumab for Metastatic Nonsquamous Non-Small Cell Lung Cancer: A Phase 3 Randomized Clinical Trial, JAMA Oncol, 10(3), 315-324, 20240301
  62. Impact of Fusobacterium nucleatum in the treatment of cancer, including radiotherapy and its future potential in esophageal cancer, JOURNAL OF RADIATION RESEARCH, 65, i126-i134, 20241216
  63. Postoperative pulmonary function of patients with lung cancer and interstitial lung abnormalities, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 72(12), 786-795, 20241201
  64. Factors influencing decision-making between surgery and chemoradiotherapy for esophageal carcinoma from the JCOG0502, FUTURE ONCOLOGY, 20(36), 2849-2854, 20241116
  65. A nomogram to predict the pathological complete response in patients with breast cancer based on the TILs-US score, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 54(9), 967-974, 20240612
  66. Postoperative Lymph Node Recurrence in Esophageal Cancer After Surgery and Prognosis of Chemoradiotherapy, Cancer Diagn Progn, 4(3), 276-280, 20240503
  67. Differences in postoperative prognosis between early-stage lung adenocarcinoma and squamous cell carcinoma, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 54(7), 813-821, 20240427
  68. Effectiveness of pleurodesis for postoperative air leaks after lung resection, JOURNAL OF CARDIOTHORACIC SURGERY, 19(1), 20240102
  69. Diagnostic performance of TILs-US score and LPBC in biopsy specimens for predicting pathological complete response in patients with breast cancer, Int J Clin Oncol, 29(12), 1860-1869, 202412
  70. Mitochondrial Metabolism as a Potential Novel Therapeutic Target for Lung Adenocarcinoma, ANTICANCER RESEARCH, 44(12), 5241-5252, 202412
  71. Reply: Tumor distance from the mediastinum as a preoperative predictor for occult mediastinal nodal metastasis, J Thorac Cardiovasc Surg, 168(5), e138-e139, 202411
  72. Relationship of Immune-Related Adverse Events with Tumor Response and Prognosis in Esophageal Squamous Cell Carcinoma Following Nivolumab Monotherapy, CANCERS, 16(20), 202410
  73. Lymph node dissection in small peripheral lung cancer: Supplemental analysis of JCOG0802/WJOG4607L, J Thorac Cardiovasc Surg, 168(3), 674-683.e1, 202409
  74. Advanced Clinical Trial Chest Surgery Group. Early chest tube removal regardless of drainage volume after anatomic pulmonary resection: A multicenter, randomized, controlled trial, J Thorac Cardiovasc Surg, 168(2), 401-410.e1, 202408
  75. The Role of Emphysema on Postoperative Prognosis in Early-Stage Nonsmall Cell Lung Cancer, ANNALS OF SURGICAL ONCOLOGY, 31(8), 5055-5063, 202408
  76. Sublobar Resection in Early Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutant, ANNALS OF THORACIC SURGERY, 118(2), 395-401, 202408
  77. ASO Author Reflections: How Does Emphysema Contribute to Poor Prognosis After Lung Cancer Surgery?, ANNALS OF SURGICAL ONCOLOGY, 31(7), 4323-4324, 202407
  78. Risk factors for recurrence of esophageal squamous cell carcinoma after pathological complete response to neoadjuvant therapy followed by esophagectomy, WORLD JOURNAL OF SURGERY, 48(7), 1700-1709, 202407
  79. Pathologic Response and Survival after Neoadjuvant Chemotherapy with Bevacizumab Followed by Surgery for Clinical Stage II/IIIA Nonsquamous Non-Small-Cell Lung Cancer: Results from a Phase II Feasibility Study (NAVAL), CANCERS, 16(13), 202407
  80. Clinical Signif icance of Preserving Pulmonary Function After Lung Resection in Early-Stage Non-Small-Cell Lung Cancer, CLINICAL LUNG CANCER, 25(4), 202406
  81. Cross-Correlation of Confocal Images for Excised Breast Tissues of Total Mastectomy, IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 71(5), 1705-1716, 202405
  82. Reply to "Correspondence: SPARC, HEG1, and the Diagnosis of Epithelioid Mesothelioma" by Churg et al, AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 48(5), 632-634, 202405
  83. Risk Factors for Recurrence of Stage I Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 117(4), 202404
  84. Second-line tislelizumab versus chemotherapy in Japanese patients with advanced or metastatic esophageal squamous cell carcinoma: subgroup analysis from RATIONALE-302, ESOPHAGUS, 21(2), 102-110, 202404
  85. Thoracic and cardiovascular surgeries in Japan during 2021Annual report by the Japanese Association for Thoracic Surgery, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 72(4), 254-291, 202404
  86. Association between prognosis and lymph node status using 18F-fluorodeoxyglucose-positron emission tomography in esophageal squamous cell carcinoma treated with esophagectomy post-neoadjuvant chemotherapy, WORLD JOURNAL OF SURGERY, 48(3), 650-661, 202403
  87. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial, LANCET RESPIRATORY MEDICINE, 12(2), 105-116, 202402
  88. Tumor distance from the mediastinum predicts N2 upstaging in clinical stage I lower-lobe non-small cell lung cancer, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 167(2), 202402
  89. NOTCH1 and CREBBP co-mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR-mutated NSCLC: translational research of phase III IMPACT study, MOLECULAR ONCOLOGY, 18(2), 305-316, 202402
  90. Prognostic factors for esophageal squamous cell carcinoma without pathological lymph node metastasis after neoadjuvant therapy and surgery, WORLD JOURNAL OF SURGERY, 48(2), 416-426, 202402
  91. Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816, CANCER SCIENCE, 115(2), 540-554, 202402
  92. SPARC Is a Novel Positive Immunohistochemical Marker of Epithelioid Mesothelioma to Differentiate It From Lung Adenocarcinoma and/or Squamous Cell Carcinoma, AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 48(2), 140-149, 202402
  93. The treatment efficacy and prognosis of each treatment in early postoperative recurrence of esophageal squamous cell carcinoma, SURGERY TODAY, 54(1), 53-63, 202401
  94. Thoracic and cardiovascular surgeries in Japan during 2020: Annual report by the Japanese Association for Thoracic Surgery, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 72(1), 61-94, 202401
  95. Discrepancy Between Radiological and Pathological Tumor Size in Early-Stage Non-Small Cell Lung Cancer: A Multicenter Study, Semin Thorac Cardiovasc Surg, 36(2), 273-281, 2024
  96. Clinicopathologic study of stage I adenosquamous carcinoma of the lung, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 53(12), 1201-1207, 20231207
  97. A multicenter propensity score-matched analysis of lymphadenectomy in N1-positve lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 53(12), 1183-1190, 20231207
  98. Risk factors for loss of pulmonary function after wedge resection for peripheral ground-glass opacity dominant lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 64(6), 20231201
  99. Hypoxia-inducible factor 1alpha modulates interstitial pneumonia-mediated lung cancer progression, J Transl Med, 21(1), 857-1892, 20231127
  100. Hypoxia-inducible factor 1ホア modulates interstitial pneumonia-mediated lung cancer progression, JOURNAL OF TRANSLATIONAL MEDICINE, 21(1), 20231127
  101. Lymph node dissection in small peripheral lung cancer: Supplemental analysis of JCOG0802/WJOG4607L, J Thorac Cardiovasc Surg, S0022-5223(23), 01099-1-1892, 20231123
  102. Preoperative predictors for recurrence sites associated with poor post-recurrence survival after surgery of non-small cell lung cancer: a multicenter study, BMC CANCER, 23(1), 20231106
  103. Anatomical segmentectomy versus wedge resection for small (≤2 cm) peripheral non -small cell lung cancer in 80 or more aged elderly patients: a randomized phase Ill study (JCOG2109, AWESOME), JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 53(11), 1077-1081, 20231105
  104. Segmentectomy for cancer control in radiologically pure-solid clinical stage IA3 lung cancer, INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY, 37(3), 20230902
  105. Wedge resection vs. segmentectomy for lung cancer measuring ≤ 2 cm with consolidation tumor ratio > 0.25, FRONTIERS IN ONCOLOGY, 13, 20230828
  106. Reply to Zhou and Yu, Eur J Cardiothorac Surg, 63(6), ezad195-1892, 20230601
  107. Reply to Zhou and Yu, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 63(6), 20230601
  108. FOXA2 Cooperates with Mutant KRAS to Drive Invasive Mucinous Adenocarcinoma of the Lung, CANCER RESEARCH, 83(9), 1443-1458, 20230501
  109. Extracellular vesicle-associated microRNA signatures related to lymphovascular invasion in early-stage lung adenocarcinoma, SCIENTIFIC REPORTS, 13(1), 20230424
  110. Real-world clinical outcomes of nivolumab and taxane as a second- or later-line therapy for recurrent or unresectable advanced esophageal squamous cell carcinoma, FRONTIERS IN ONCOLOGY, 13, 20230417
  111. The efficacy of thoracoscopic surgery for descending necrotizing mediastinitis, INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY, 36(4), 20230403
  112. Extracellular vesicle-associated microRNA signatures related to lymphovascular invasion in early-stage lung adenocarcinoma, SCIENTIFIC REPORTS, 13(1), 20230324
  113. Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma, BMC CANCER, 23(1), 20230314
  114. Reply to Sanz-Santos et al, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 63(3), 20230301
  115. Segmentectomy preserves better immune-nutritional status than lobectomy in patients with early-stage lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 63(2), 20230203
  116. Tumour location predicts occult N1 nodal metastasis in clinical stage I non-small-cell lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 63(2), 20230203
  117. Wedge resection is an acceptable treatment option for radiologically low-grade lung cancer with solid predominance, INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY, 36(1), 20230109
  118. Lack of Association of Plasma Levels of Soluble Programmed Cell Death Protein 1, Programmed Death-Ligand 1, and CTLA-4 With Survival for Stage II to IIIA NSCLC After Complete Resection and Adjuvant Chemotherapy, JTO CLINICAL AND RESEARCH REPORTS, 4(12), 202312
  119. Musashi-1 Is a Novel Immunohistochemical Marker of Neuroendocrine Carcinoma of the Lung, CANCERS, 15(23), 202312
  120. Asian Perspective on Lung Cancer Screening, THORACIC SURGERY CLINICS, 33(4), 385-400, 202311
  121. Thoracic and cardiovascular surgeries in Japan during 2019 Annual report by the Japanese Association for Thoracic Surgery, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 71(10), 595-628, 202310
  122. Long-term outcome of patients with peripheral ground-glass opacity-dominant lung cancer after sublobar resections, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 166(4), 1222-+, 202310
  123. Segmentectomy and Wedge Resection Should Be Distinguished as Sublobar Resections for Lung Cancer, Ann Thorac Surg, 116(4), 859, 202310
  124. Risk factors for aortoesophageal fistula in cT4b esophageal squamous cell carcinoma after definitive radiation therapy, JOURNAL OF THORACIC DISEASE, 15(10), 5319-5329, 202310
  125. Early chest tube removal regardless of drainage volume after anatomic pulmonary resection: A multicenter, randomized, controlled trial, Thorac Cardiovasc Surg, S0022-5223(23), 01007-3, 202310
  126. Sublobar Resection for Non-Small Cell Lung Cancer in Octogenarians: A Prospective, Multicenter Study, ANNALS OF THORACIC SURGERY, 116(3), 543-551, 202309
  127. Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non-small-cell lung cancer in KEYNOTE-407, CANCER SCIENCE, 114(8), 3330-3341, 202308
  128. Prospective, Multi-Institutional Observational Study of Deterioration in Activities of Daily Living in Elderly Patients After Lung Cancer Surgery, JTO CLINICAL AND RESEARCH REPORTS, 4(8), 202308
  129. The Efficacy of PCSK9 Inhibitors in Treating Hypercholesterolemia Caused by Lorlatinib: A Report of Two Cases., CLINICAL LUNG CANCER, 24(5), e176-e178, 202307
  130. Esophageal Neuroendocrine Carcinoma With Pathological Complete Response After Neoadjuvant Chemotherapy Followed by Robot-assisted Surgery: A Case Report, ANTICANCER RESEARCH, 43(7), 3289-3293, 202307
  131. Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial, Lancet Respir Med, 11(6), 540-549, 202306
  132. Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground- glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial, LANCET RESPIRATORY MEDICINE, 11(6), 540-549, 202306
  133. Current clinical trials with non-coding RNA-based therapeutics in malignant diseases: A systematic review, TRANSLATIONAL ONCOLOGY, 31, 202305
  134. First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50), ESOPHAGUS, 20(2), 291-301, 202304
  135. Effectiveness of taxanes following nivolumab in patients with advanced esophageal squamous cell carcinoma: a retrospective chart review of patients in ATTRACTION-3, ESOPHAGUS, 20(2), 302-308, 202304
  136. Feasibility of repeated ipsilateral anatomical pulmonary resection, SURGERY TODAY, 53(3), 379-385, 202303
  137. Complications and Survival After Lung Cancer Resection in Interstitial Lung Disease, Ann Thorac Surg, 115(3), 701-708, 202303
  138. Long-term results of chemoradiotherapy with elective nodal irradiation for resectable locally advanced esophageal cancer in three-dimensional planning system, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 28(3), 382-391, 202303
  139. Usefulness of serum S100A4 and positron-emission tomography on lung cancer accompanied by interstitial pneumonia, THORACIC CANCER, 14(4), 381-388, 202302
  140. Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial-Mesenchymal Transition, CANCERS, 15(4), 202302
  141. Impact of oral hygiene on febrile neutropenia during breast cancer chemotherapy, BREAST CANCER, 30(1), 151-155, 202301
  142. [Dawn of Radical Segmentectomy for Small Sized Peripheral Non-small Cell Lung Cancer]., Kyobu Geka, 76(1), 4-8, 202301
  143. 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts Tumor Immune Microenvironment Function in Early Triple-negative Breast Cancer, ANTICANCER RESEARCH, 43(1), 127-136, 202301
  144. Ability of Blood Cell Parameters to Predict Clinical Outcomes of Nivolumab Monotherapy in Advanced Esophageal Squamous Cell Carcinoma, ONCOTARGETS AND THERAPY, 16, 263-273, 2023
  145. Blood biomarkers as predictors of pathological lymph node metastasis in clinical stage T1N0 esophageal squamous cell carcinoma, DISEASES OF THE ESOPHAGUS, 36(1), 20221231
  146. Advanced Clinical Trial Chest Surgery Group (ACTG).S-1 + Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous Cell Carcinoma: Results of a Phase II Trial, Ann Surg Oncol, 29(13), 8198-8206, 20221229
  147. Discrepancy Between Radiological and Pathological Tumor Size in Early-Stage Non-Small Cell Lung Cancer: A Multicenter Study, Semin Thorac Cardiovasc Surg, S1043-0679(22), 00277-5, 20221210
  148. Impact of the amount of preoperative erector spinae muscle in stage I non-small-cell lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 63(1), 20221202
  149. Prevalence of immune-related adverse events and anti-tumor efficacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumors, BMC CANCER, 22(1), 20221129
  150. First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/ONO-4538-50), ESOPHAGUS, 20(2), 291-301, 20221119
  151. Phase I Study of Tremelimumab Monotherapy or in Combination With Durvalumab in Japanese Patients With Advanced Solid Tumors or Malignant Mesothelioma, ONCOLOGIST, 27(9), E703-E722, 20220902
  152. The prognostic impact of the ground-glass opacity component in nearly pure-solid stage IA non-small-cell lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 62(3), 20220803
  153. Three-Year Follow-Up and Response-Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3), CLINICAL CANCER RESEARCH, 28(15), 20220801
  154. Possible Therapeutic Utility of anti-Cell Adhesion Molecule 1 Antibodies for Malignant Pleural Mesothelioma, FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 10, 20220712
  155. Oncological outcome of segmentectomy for early-stage non-small-cell lung cancer with invasive characteristics: a multicentre study, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 62(2), 20220711
  156. Interstitial pneumonia and advanced age negatively influence postoperative pulmonary function, INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 34(5), 753-759, 20220502
  157. Segmentectomy versus wedge resection for radiological solid predominant and low metabolic non-small cell lung cancer, INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 34(5), 814-821, 20220502
  158. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L) : a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial, LANCET, 399(10335), 1607-1617, 20220423
  159. The ratio of CD8+lymphocytes to tumor-infiltrating suppressive FOXP3+effector regulatory T cells is associated with treatment response in invasive breast cancer, DISCOVER ONCOLOGY, 13(1), 20220419
  160. Commentary: Segmentectomy as a standard surgery, a new era in small sized, peripheral, non-small cell lung cancer, JTCVS Tech, 20(12), 210-211, 20220220
  161. Segmentectomy versus lobectomy for solid predominant cN0 lung cancer: analysis using visual evaluation of positron emission tomography, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 61(2), 279-286, 20220124
  162. Malignant prediction of incidental findings using ring-type dedicated breast positron emission tomography, SCIENTIFIC REPORTS, 12(1), 20220121
  163. Randomized Phase III Study of Gefitinib Versus Cisplatin Plus Vinorelbine for Patients With Resected Stage II-IIIA Non-Small-Cell Lung Cancer With EGFR Mutation (IMPACT), JOURNAL OF CLINICAL ONCOLOGY, 40(3), 231-+, 20220120
  164. Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE, JOURNAL OF CLINICAL ONCOLOGY, 40(2), 180-+, 20220110
  165. Risk factors for recurrence of stage I epidermal growth factor receptor mutated lung adenocarcinoma, Ann Thorac Surg, 49(13), 1891-1892, 202212
  166. ASO Visual Abstract: S-1+Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous Cell Carcinoma: Results of a Phase II Trial, ANNALS OF SURGICAL ONCOLOGY, 29(13), 8209-8210, 202212
  167. Effectiveness of taxanes following nivolumab in patients with advanced esophageal squamous cell carcinoma: a retrospective chart review of patients in ATTRACTION-3, ESOPHAGUS, 202212
  168. Effect of Secondary Prophylactic G-CSF on the Occurrence of Febrile Neutropenia in Breast Cancer, ANTICANCER RESEARCH, 42(12), 5945-5949, 202212
  169. Correlation Between Tumor Uptake on FDG-PET and Malignant Features in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy Followed by Surgery, ANTICANCER RESEARCH, 42(12), 6037-6045, 202212
  170. The intersegmental pulmonary vein is not always located on the intersegmental plane of the lung: Evaluation with 3-dimensional volume-rendering image reconstruction, JTCVS TECHNIQUES, 16, 132-138, 202212
  171. Adjuvant atezolizumab in Japanese patients with resected stage IB-IIIA non-small cell lung cancer (IMpower010), CANCER SCIENCE, 113(12), 4327-4338, 202212
  172. Segmentectomy for clinically early-stage primary squamous cell carcinoma of the lung, THORACIC CANCER, 13(24), 3477-3485, 202212
  173. Leukocyte Telomeric G-Tail Length Shortening Is Associated with Esophageal Cancer Recurrence, JOURNAL OF CLINICAL MEDICINE, 11(24), 202212
  174. S-1+Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous Cell Carcinoma: Results of a Phase II Trial, ANNALS OF SURGICAL ONCOLOGY, 29(13), 8198-8206, 202212
  175. Segmentectomy for Spread Through Air Spaces-positive Lung Adenocarcinoma, Ann Thorac Surg, 114(5), 1989-1990, 202211
  176. The impact of epidermal growth factor receptor mutation status on adjuvant chemotherapy for patients with high-risk stage I lung adenocarcinoma, J Thorac Cardiovasc Surg, 164(5), 1306-1315.e4, 202211
  177. Committee for Scientific Affairs, The Japanese Association for Chest Surgery. The C-reactive protein to albumin ratio is a prognostic factor for stage I non-small cell lung cancer in elderly patients: JACS1303, Surg Today, 52(10), 1463-1471, 202210
  178. The tumor-infiltrating lymphocyte ultrasonography score can provide a diagnostic prediction of lymphocyte-predominant breast cancer preoperatively, JOURNAL OF MEDICAL ULTRASONICS, 49(4), 709-717, 202210
  179. The C-reactive protein to albumin ratio is a prognostic factor for stage I non-small cell lung cancer in elderly patients: JACS1303, SURGERY TODAY, 52(10), 1463-1471, 202210
  180. Dual-phase FDG PET/CT for predicting prognosis in operable breast cancer, BREAST, 65, 98-103, 202210
  181. Randomized phase II trial of pemetrexed-cisplatin plus bevacizumab or thoracic radiotherapy followed by surgery for stage IIIA (N2) nonsquamous non-small cell lung cancer, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 164(3), 661-+, 202209
  182. Prognostic value of quantitative parameters for esophageal squamous cell carcinoma determined by preoperative FDG-PET after trimodal therapy, SURGERY, 172(2), 584-592, 202208
  183. Evaluation of Neoadjuvant Chemoradiotherapy Followed by Surgery for Borderline Resectable Esophageal Squamous Cell Carcinoma, WORLD JOURNAL OF SURGERY, 46(8), 1934-1943, 202208
  184. Psychological states regarding adjuvant chemotherapy in patients with non-small cell lung cancer, Cancer Treat Res Commun, 23(5), 393-401, 202207
  185. A Multicenter Study of Complex Segmentectomy Versus Wedge Resection in Clinical Stage 0-IA Non-Small Cell Lung Cancer, CLINICAL LUNG CANCER, 23(5), 393-401, 202207
  186. Neoadjuvant pemetrexed plus cisplatin followed by pleurectomy for malignant pleural mesothelioma, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 163(6), 1940-+, 202206
  187. Exploratory Analysis Comparing Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blind, Phase 3 Study (CONSOLE), ONCOLOGY AND THERAPY, 10(1), 253-262, 202206
  188. Sensitivity and optimal clinicopathological features for mutation-targeted liquid biopsy in pN0M0 EGFR-mutant lung adenocarcinoma, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 148(6), 1419-1428, 202206
  189. Role of ground-glass opacity in pure invasive and lepidic component in pure solid lung adenocarcinoma for predicting aggressiveness, JTCVS Open, 2(11), 300-316, 202205
  190. Adjuvant Chemotherapy for High-risk Pathologic Stage I Non-Small Cell Lung Cancer, ANNALS OF THORACIC SURGERY, 113(5), 1608-1616, 202205
  191. Role of Soluble Receptor for Advanced Glycation End Products in Postoperative Fibrotic Lung Injury, ANNALS OF THORACIC SURGERY, 113(5), 1617-1623, 202205
  192. The TILs-US score on ultrasonography can predict the pathological response to neoadjuvant chemotherapy for human epidermal growth factor receptor 2-positive and triple-negative breast cancer, SURGICAL ONCOLOGY-OXFORD, 41, 202205
  193. Clinical Outcomes of Esophagectomy and Chemoradiotherapy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma, ANTICANCER RESEARCH, 42(5), 2791-2795, 202205
  194. Prognostic Impact of Mediastinal Lymph Node Dissection in Octogenarians With Lung Cancer: JACS1303, CLINICAL LUNG CANCER, 23(3), E176-E184, 202205
  195. Complex Segmentectomy for Hypermetabolic Clinical Stage IA Non-Small Cell Lung Cancer, ANNALS OF THORACIC SURGERY, 113(4), 1317-1324, 202204
  196. Japanese Current Status of Curative-Intent Surgery for Malignant Pleural Mesothelioma, ANNALS OF THORACIC SURGERY, 113(4), 1348-1353, 202204
  197. Recurrent esophageal adenocarcinoma derived from ectopic gastric mucosa: A case report, THORACIC CANCER, 13(6), 876-879, 202203
  198. Neutrophil-to-Lymphocyte Ratio as a Predictor of Postoperative Recurrence and Prognosis in Oesophageal Squamous Cell Carcinoma, ANTICANCER RESEARCH, 42(3), 1499-1507, 202203
  199. Prognostic biomarker study in patients with clinical stage I esophageal squamous cell carcinoma: JCOG0502-A1, CANCER SCIENCE, 113(3), 1018-1027, 202203
  200. Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial, LANCET RESPIRATORY MEDICINE, 10(1), 72-82, 202201
  201. Preoperative Cumulative Smoking Dose on Lung Cancer Surgery in a Japanese Nationwide Database, ANNALS OF THORACIC SURGERY, 113(1), 237-243, 202201
  202. A risk model for prolonged air leak after lobectomy using the National Clinical Database in Japan, SURGERY TODAY, 52(1), 69-74, 202201
  203. p Clinical Behavior of Combined Versus Pure High-Grade Neuroendocrine Carcinoma, CLINICAL LUNG CANCER, 23(1), E9-+, 202201
  204. Psychological states regarding adjuvant chemotherapy in patients with non-small cell lung cancer, CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 32, 2022
  205. Prognostic Factors for Patients With Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy Followed by Surgery, IN VIVO, 36(6), 2852-2860, 2022
  206. Clinicopathologic Features and Response to Therapy of NRG1 Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter Registry, JOURNAL OF CLINICAL ONCOLOGY, 39(25), 2791-+, 20210901
  207. Clinical Behavior of Combined Versus Pure High-Grade Neuroendocrine Carcinoma., Clin Lung Cancer, 20210704
  208. Sensitivity and optimal clinicopathological features for mutation-targeted liquid biopsy in pN0M0 EGFR-mutant lung adenocarcinoma., J Cancer Res Clin Oncol, 20210703
  209. Identification of High-Risk of Recurrence in Clinical Stage I Non-Small Cell Lung Cancer, FRONTIERS IN ONCOLOGY, 11, 20210607
  210. Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer, BMC PULMONARY MEDICINE, 21(1), 20210602
  211. Is Wedge Resection Optimal for Octogenarians with Early-Stage Non-Small-Cell Lung Cancer Compared with Lobectomy/Segmentectomy?, Ann Surg Oncol, 20210523
  212. Complex Segmentectomy for Hypermetabolic Clinical Stage IA Non-Small Cell Lung Cancer., Ann Thorac Surg, 20210520
  213. Clinical effect of the pathological axillary assessment method in breast cancer without clinical nodal metastasis., Breast Cancer, 20210519
  214. Preoperative nivolumab to evaluate pathological response in patients with stage I non-small cell lung cancer: a study protocol of phase II trial (POTENTIAL)., BMJ Open, 20210517
  215. Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patients, SCIENTIFIC REPORTS, 11(1), 20210512
  216. Surgical challenges in multimodal treatment of N2-stage IIIA non-small cell lung cancer., Jpn J Clin Oncol, 20210503
  217. Breast cancer detection by dedicated breast positron emission tomography according to the World Health Organization classification of breast tumors., Eur J Surg Oncol, 20210503
  218. Transition of Treatment for Ground Glass Opacity-Dominant Non-Small Cell Lung Cancer, FRONTIERS IN ONCOLOGY, 11, 20210415
  219. Bronchial mucosal ablation for bronchial stump closure in right pneumonectomy: a case report., J Med Case Rep, 20210218
  220. Bronchial mucosal ablation for bronchial stump closure in right pneumonectomy: a case report, JOURNAL OF MEDICAL CASE REPORTS, 15(1), 20210218
  221. Preoperative cumulative smoking dose on lung cancer surgery in a Japanese nationwide database., Ann Thorac Surg, 20210215
  222. Certified thoracic surgeons in Japan: a national database survey on risk-adjusted mortality associated with lung resection., Surg Today, 20210130
  223. Performance of dedicated breast positron emission tomography in the detection of small and low-grade breast cancer., Breast Cancer Res Treat, 20210123
  224. A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study)., Ther Adv Med Oncol, 20210121
  225. Salvage surgery for non-small cell lung cancer after tyrosine kinase inhibitor treatment., Lung Cancer, 20210110
  226. Descending necrotizing mediastinitis and the proposal of a new classification, JTCVS OPEN, 8, 633-647, 202112
  227. ASO Author Reflection: Position of the Complex Segmentectomy on Postoperative Pulmonary Function, ANNALS OF SURGICAL ONCOLOGY, 28(13), 8356-8357, 202112
  228. Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 147(12), 3709-3718, 202112
  229. Postoperative Pulmonary Function After Complex Segmentectomy, ANNALS OF SURGICAL ONCOLOGY, 28(13), 8347-8355, 202112
  230. Parallel-Group Controlled Trial of Surgery Versus Chemoradiotherapy in Patients With Stage I Esophageal Squamous Cell Carcinoma, GASTROENTEROLOGY, 161(6), 1878-+, 202112
  231. Pathological high malignant grade is higher risk of recurrence in pN0M0 invasive lung adenocarcinoma, even with small invasive size, THORACIC CANCER, 12(23), 3141-3149, 202112
  232. Prospective Randomized Trial of Early Postoperative Enteral and Total Parenteral Nutrition for Treating Esophageal Cancer, ANTICANCER RESEARCH, 41(12), 6237-6246, 202112
  233. ASO Author Reflections: Is Wedge Resection Optimal for Octogenarians with Early-Stage Non-Small-Cell Lung Cancer Compared with Lobectomy/Segmentectomy?, ANNALS OF SURGICAL ONCOLOGY, 28(12), 7228-7229, 202111
  234. Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303, ANNALS OF SURGICAL ONCOLOGY, 28(12), 7219-7227, 202111
  235. Systematic Versus Lobe-Specific Mediastinal Lymphadenectomy for Hypermetabolic Lung Cancer, ANNALS OF SURGICAL ONCOLOGY, 28(12), 7162-7171, 202111
  236. Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non-small-cell Lung Cancer: SQUAT trial 12119L), CLINICAL LUNG CANCER, 22(6), 596-600, 202111
  237. Risk of death due to other causes is lower among octogenarians with non-small cell lung cancer after wedge resection than lobectomy/segmentectomy, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 51(10), 1561-1569, 202110
  238. Comparison of cancer control between segmentectomy and wedge resection in patients with clinical stage IA non-small cell lung cancer, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 162(4), 1244-+, 202110
  239. Clinical effect of the pathological axillary assessment method in breast cancer without clinical nodal metastasis, BREAST CANCER, 28(5), 1016-1022, 202109
  240. Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study), BREAST CANCER, 28(5), 1023-1037, 202109
  241. Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer, BREAST CANCER, 28(5), 1062-1071, 202109
  242. Prediction of the tumor response and survival based on computed tomography in esophageal squamous cell carcinoma after trimodality therapy, SURGERY TODAY, 51(9), 1496-1505, 202109
  243. Salvage Surgery for Non-Small Cell Lung Cancer After Definitive Radiotherapy, ANNALS OF THORACIC SURGERY, 112(3), 862-873, 202109
  244. Segmentectomy vs Lobectomy for Clinical Stage IA Lung Adenocarcinoma With Spread Through Air Spaces, ANNALS OF THORACIC SURGERY, 112(3), 935-943, 202109
  245. Certified thoracic surgeons in Japan: a national database survey on risk-adjusted mortality associated with lung resection, SURGERY TODAY, 51(8), 1268-1275, 202108
  246. The impact of pathological lymph node metastasis with lymphatic invasion on the survival of patients with clinically node-negative non-small cell lung cancer: A multicenter study, LUNG CANCER, 158, 9-14, 202108
  247. Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer, SUPPORTIVE CARE IN CANCER, 29(7), 3507-3512, 202107
  248. Breast cancer detection by dedicated breast positron emission tomography according to the World Health Organization classification of breast tumors, EJSO, 47(7), 1588-1592, 202107
  249. Prognostic role of interstitial pneumonia with or without emphysema in patients with clinical stage I lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 51(7), 1123-1131, 202107
  250. Prediction of Acute Exacerbation of Interstitial Pneumonia Using Visual Evaluation of PET, ANNALS OF THORACIC SURGERY, 112(1), 264-270, 202107
  251. Anatomical location and number of metastatic lymph nodes for prognosis of non-small cell lung cancer, JOURNAL OF THORACIC DISEASE, 13(7), 4083-+, 202107
  252. Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma, JTO CLINICAL AND RESEARCH REPORTS, 2(6), 202106
  253. Comparison of Open and Thoracoscopic Esophagectomy in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma After Neoadjuvant Therapy, ANTICANCER RESEARCH, 41(6), 3011-3021, 202106
  254. Performance of dedicated breast positron emission tomography in the detection of small and low-grade breast cancer, BREAST CANCER RESEARCH AND TREATMENT, 187(1), 125-133, 202105
  255. Long-Term Outcomes After Sublobar Resection Versus Lobectomy in Patients With Clinical Stage IA Lung Adenocarcinoma Meeting the Node-Negative Criteria Defined by High-Resolution Computed Tomography and [F-18]-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography, CLINICAL LUNG CANCER, 22(3), E431-E437, 202105
  256. Patient Selection of Sublobar Resection Using Visual Evaluation of Positron-Emission Tomography (PET) for Early-Stage Lung Adenocarcinoma, ANNALS OF SURGICAL ONCOLOGY, 28(4), 2068-2075, 202104
  257. Impact of postoperative pleurodesis on pulmonary function after lung segmentectomy, JTCVS OPEN, 5, 110-118, 202103
  258. Clinical Efficacy and Safety of Nivolumab in Japanese Patients With Malignant Pleural Mesothelioma: 3-Year Results of the MERIT Study, JTO CLINICAL AND RESEARCH REPORTS, 2(3), 202103
  259. Distribution of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma After Trimodal Therapy, ANNALS OF SURGICAL ONCOLOGY, 28(3), 1798-1807, 202103
  260. Salvage surgery for non-small cell lung cancer after tyrosine kinase inhibitor treatment, LUNG CANCER, 153, 108-116, 202103
  261. Novel technique for identification of the pulmonary intersegmental plane using manual jet ventilation during pulmonary segmentectomy, VIDEOSURGERY AND OTHER MINIINVASIVE TECHNIQUES, 16(1), 169-174, 202103
  262. Oncologic Outcomes of Complex Segmentectomy: A Multicenter Propensity Score-Matched Analysis, ANNALS OF THORACIC SURGERY, 111(3), 1044-1051, 202103
  263. Prediction of Unexpected N2 Disease Associated With Clinical T1-2N0-1M0 Non-Small-Cell Lung Cancer, CLINICAL LUNG CANCER, 22(2), 120-+, 202103
  264. Surgical Procedure Selection for Stage I Lung Cancer: Complex Segmentectomy versus Wedge Resection, CLINICAL LUNG CANCER, 22(2), E224-E233, 202103
  265. Surgical challenges in multimodal treatment of N2-stage IIIA non-small cell lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 51(3), 333-344, 202103
  266. Appropriate Extent of Lymphadenectomy in Segmentectomy: A Multicenter Study, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 51(3), 451-458, 202103
  267. Utility of Newly Proposed Grading System From International Association for the Study of Lung Cancer for Invasive Lung Adenocarcinoma, JTO CLINICAL AND RESEARCH REPORTS, 2(2), 202102
  268. Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lung, TRANSLATIONAL LUNG CANCER RESEARCH, 10(2), 766-+, 202102
  269. Thoracic and cardiovascular surgeries in Japan during 2018 Annual report by the Japanese Association for Thoracic Surgery, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 69(1), 179-212, 202101
  270. Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3), ESOPHAGUS, 18(1), 90-99, 202101
  271. A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study), THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 13, 202101
  272. Long-term results of definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma, JOURNAL OF RADIATION RESEARCH, 62(1), 142-148, 202101
  273. Recent advances and future perspectives in adjuvant and neoadjuvant immunotherapies for lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 51(1), 28-36, 202101
  274. Preoperative nivolumab to evaluate pathological response in patients with stage I non-small cell lung cancer: a study protocol of phase II trial (POTENTIAL), BMJ OPEN, 11(3), 2021
  275. Complete Response for Advanced Hepatocellular Carcinoma by Conversion Surgery Therapy Following a Good Response of Regorafenib Despite Rapid Progressive Disease with Sorafenib, INTERNAL MEDICINE, 60(13), 2047-2053, 2021
  276. Randomized Phase III Study of Irinotecan Plus Cisplatin Versus Etoposide Plus Cisplatin for Completely Resected High-Grade Neuroendocrine Carcinoma of the Lung: JCOG1205/1206, JOURNAL OF CLINICAL ONCOLOGY, 38(36), 4292-+, 20201220
  277. Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE), JOURNAL OF CLINICAL ONCOLOGY, 38(34), 20201201
  278. Microwave Breast Imaging Using Rotational Bistatic Impulse Radar for the Detection of Breast Cancer: Protocol for a Prospective Diagnostic Study, JOURNAL OF MEDICAL INTERNET RESEARCH, 22(10), 20201019
  279. Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma, PLOS ONE, 15(4), 20200406
  280. A phase III study of adjuvant chemotherapy in patients with completely resected, node-negative non-small cell lung cancer (JCOG 0707), JTCVS OPEN, 4, 90-102, 202012
  281. A Two-Stage Rotational Surface Clutter Suppression Method for Microwave Breast Imaging With Multistatic Impulse-Radar Detector, IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT, 69(12), 9586-9598, 202012
  282. Prognosis of segmentectomy and lobectomy for radiologically aggressive small-sized lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 58(6), 1245-1253, 202012
  283. Src-Homology 2 Domain-Containing Phosphatase 2 in Resected EGFR Mutation-Positive Lung Adenocarcinoma, JTO CLINICAL AND RESEARCH REPORTS, 1(4), 202011
  284. Comparing Segmentectomy and Lobectomy for Clinical Stage IA Solid-dominant Lung Cancer Measuring 2.1 to 3 cm, CLINICAL LUNG CANCER, 21(6), E528-E538, 202011
  285. Clinical features and prognosis of clinical N0 non-small cell lung cancer exceeding 30 mm, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 50(11), 1306-1312, 202011
  286. Predictions of Pathological Features and Recurrence Based on FDG-PET Findings of Esophageal Squamous Cell Carcinoma after Trimodal Therapy, ANNALS OF SURGICAL ONCOLOGY, 27(11), 4422-4430, 202010
  287. Microwave Breast Imaging Using Rotational Bistatic Impulse Radar for the Detection of Breast Cancer: Protocol for a Prospective Diagnostic Study, JMIR RESEARCH PROTOCOLS, 9(10), 202010
  288. Prediction of Lymph Node Metastasis Using Semiquantitative Evaluation of PET for Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 110(3), 1036-1042, 202009
  289. SOX6 is a Novel Immunohistochemical Marker for Differential Diagnosis of Epithelioid Mesothelioma From Lung Adenocarcinoma, AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 44(9), 1259-1265, 202009
  290. Wedge resection as an alternative treatment for octogenarian and older patients with early-stage non-small-cell lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 50(9), 1051-1057, 202009
  291. Sublobar resection versus lobectomy for patients with resectable stage I non-small cell lung cancer with idiopathic pulmonary fibrosis: a phase III study evaluating survival (JCOG1708, SURPRISE), JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 50(9), 1076-1079, 202009
  292. Prevention of Postoperative Prolonged Air Leak After Pulmonary Resection, THORACIC SURGERY CLINICS, 30(3), 305-+, 202008
  293. Risk Factors for Recurrence in Esophageal Squamous Cell Carcinoma Without Pathological Complete Response After Trimodal Therapy, ANTICANCER RESEARCH, 40(8), 4387-4394, 202008
  294. LPrognostic Impact of Programmed Death-ligand 1 and Surrounding Immune Status on Stage I Lung Cancer, CLINICAL LUNG CANCER, 21(4), E302-E314, 202007
  295. Are segmentectomy and lobectomy comparable in terms of curative intent for early stage non-small cell lung cancer?, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 68(7), 703-706, 202007
  296. Evaluation of plasma EGFR mutation as an early predictor of response of erlotinib plus bevacizumab treatment in the NEJ026 study, EBIOMEDICINE, 57, 202007
  297. Investigation of surgical technique for bronchial stump closure after lobectomy in animal model, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 68(6), 609-614, 202006
  298. Tumor-infiltrating Lymphocyte Score Based on FDG PET/CT for Predicting the Effect of Neoadjuvant Chemotherapy in Breast Cancer, ANTICANCER RESEARCH, 40(6), 3395-3400, 202006
  299. Classification of Abnormal Findings on Ring-type Dedicated Breast PET for the Detection of Breast Cancer, ANTICANCER RESEARCH, 40(6), 3491-3497, 202006
  300. Predicting the presence of breast cancer using circulating small RNAs, including those in the extracellular vesicles, CANCER SCIENCE, 111(6), 2104-2115, 202006
  301. Biological Effects of Low-Dose Chest CT on Chromosomal DNA, RADIOLOGY, 295(2), 439-445, 202005
  302. Solid Tumor Size of 2 cm Divides Outcomes of Patients With Mixed Ground Glass Opacity Lung Tumors, ANNALS OF THORACIC SURGERY, 109(5), 1530-1536, 202005
  303. Diagnostic performance of peripheral leukocyte telomere G-tail length for detecting breast cancer, CANCER SCIENCE, 111(5), 1856-1861, 202005
  304. Prospective, randomized, cross-over pilot study of the effects of Rikkunshito, a Japanese traditional herbal medicine, on anorexia and plasma-acylated ghrelin levels in lung cancer patients undergoing cisplatin-based chemotherapy, INVESTIGATIONAL NEW DRUGS, 38(2), 485-492, 202004
  305. Predicting Severe Postoperative Complication in Patients With Lung Cancer and Interstitial Pneumonia, ANNALS OF THORACIC SURGERY, 109(4), 1054-1060, 202004
  306. Thoracic and cardiovascular surgeries in Japan during 2017 Annual report by the Japanese Association for Thoracic Surgery, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 68(4), 414-449, 202004
  307. Initial experience of robotic anatomical segmentectomy for non-small cell lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 50(4), 440-445, 202004
  308. Intense Expression of EGFR L858R Characterizes the Micropapillary Component and L858R Is Associated with the Risk of Recurrence in pN0M0 Lung Adenocarcinoma with the Micropapillary Component, ANNALS OF SURGICAL ONCOLOGY, 27(3), 945-955, 202003
  309. Positive EGFR mutation status is a risk of recurrence in pN0-1 lung adenocarcinoma when combined with pathological stage and histological subtype: A retrospective multi-center analysis, LUNG CANCER, 141, 107-113, 202003
  310. Tumor Response in Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemotherapy Followed by Surgery, ANTICANCER RESEARCH, 40(2), 1153-1160, 202002
  311. Complex segmentectomy in the treatment of stage IA non-small-cell lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 57(1), 114-121, 202001
  312. Albumin-globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 25(1), 74-81, 202001
  313. Albumin-globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 25(1), 74-81, 202001
  314. Thoracoscopic double-flap reconstruction for esophagogastric junction cancer: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 67, 102-105, 2020
  315. Successful Management of Esophageal Cancer With Perforation Using Bypass Surgery Followed by Definitive Chemoradiotherapy, IN VIVO, 34(4), 2169-2172, 2020
  316. Targeting PKC iota-PAK1 signaling pathways in EGFR and KRAS mutant adenocarcinoma and lung squamous cell carcinoma, CELL COMMUNICATION AND SIGNALING, 17(1), 20191028
  317. Guanylate binding protein 1 (GBP-1) promotes cell motility and invasiveness of lung adenocarcinoma, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 518(2), 266-272, 20191015
  318. Wedge resection versus segmentectomy in patients with stage I non-small-cell lung cancer unfit for lobectomy, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 49(12), 1134-1142, 201912
  319. High-Risk Factors for Recurrence of Stage I Lung Adenocarcinoma: Follow-up Data From JCOG0201, ANNALS OF THORACIC SURGERY, 108(5), 1484-1490, 201911
  320. Identification of Axillary Lymph Node Metastasis in Patients With Breast Cancer Using Dual-Phase FDG PET/CT, AMERICAN JOURNAL OF ROENTGENOLOGY, 213(5), 1129-1135, 201911
  321. Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial, LANCET ONCOLOGY, 20(11), 1506-1517, 201911
  322. The relationship between ring-type dedicated breast PET and immune microenvironment in early breast cancer, BREAST CANCER RESEARCH AND TREATMENT, 177(3), 651-657, 201910
  323. Novel tumor-infiltrating lymphocytes ultrasonography score based on ultrasonic tissue findings predicts tumor-infiltrating lymphocytes in breast cancer, BREAST CANCER, 26(5), 573-580, 201909
  324. Breast cancer cell motility is promoted by 14-3-3 gamma, BREAST CANCER, 26(5), 581-593, 201909
  325. Postoperative Recurrence and Survival After Segmentectomy for Clinical Stage 0 or IA Lung Cancer, CLINICAL LUNG CANCER, 20(5), 397-+, 201909
  326. Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 158(3), 895-907, 201909
  327. Synchronicity of genetic variants between primary sites and metastatic lymph nodes, and prognostic impact in nodal metastatic lung adenocarcinoma, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 145(9), 2325-2333, 201909
  328. Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer, RESPIRATORY INVESTIGATION, 57(5), 451-459, 201909
  329. Clinical Efficacy and Safety of Nivolumab: Results of a Multicenter, Open-label, Single-arm, Japanese Phase II study in Malignant Pleural Mesothelioma (MERIT), CLINICAL CANCER RESEARCH, 25(18), 5485-5492, 201909
  330. Therapeutic value of postmastectomy radiation therapy for T1-2 breast cancer with 1-3 positive lymph nodes, JOURNAL OF RADIATION ONCOLOGY, 8(3), 323-328, 201909
  331. Detectability of Breast Tumors in Excised Breast Tissues of Total Mastectomy by IR-UWB-Radar-Based Breast Cancer Detector, IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 66(8), 2296-2305, 201908
  332. Long-term Esophageal Cancer Survivor Treated by Bypass for Esophagobronchial Fistula After Chemoradiotherapy: A Case Report, ANTICANCER RESEARCH, 39(8), 4399-4403, 201908
  333. Clinical Significance of F-18-Fluorodeoxyglucose-Positron Emission Tomography-Positive Lymph Nodes to Outcomes of Trimodal Therapy for Esophageal Squamous Cell Carcinoma, ANNALS OF SURGICAL ONCOLOGY, 26(6), 1869-1878, 201906
  334. Traditional Japanese herbal medicine rikkunshito increases food intake and plasma acylated ghrelin levels in patients with esophageal cancer treated by cisplatin-based chemotherapy, JOURNAL OF THORACIC DISEASE, 11(6), 2470-2478, 201906
  335. Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial, LANCET ONCOLOGY, 20(5), 625-635, 201905
  336. Surgical Outcomes of Complex Versus Simple Segmentectomy for Stage I Non-Small Cell Lung Cancer, ANNALS OF THORACIC SURGERY, 107(4), 1032-1039, 201904
  337. Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblasts, JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 23(4), 2984-2994, 201904
  338. Prediction of biological characteristics of breast cancer using dual-phase FDG PET/CT, EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 46(4), 831-837, 201904
  339. Thoracic and cardiovascular surgery in Japan in 2016: Annual report by The Japanese Association for Thoracic Surgery, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 67(4), 377-411, 201904
  340. Risk assessments for broncho-pleural fistula and respiratory failure after lung cancer surgery by National Clinical Database Japan, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 67(3), 297-305, 201903
  341. Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma, HISTOPATHOLOGY, 74(4), 545-554, 201903
  342. Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma, ANTICANCER RESEARCH, 39(3), 1433-1440, 201903
  343. Prolonged post-recurrence survival following pleurectomy/decortication for malignant pleural mesothelioma, ONCOLOGY LETTERS, 17(3), 3607-3614, 201903
  344. Lung cancer risk stratification using methylation profile in the oral epithelium, Asian Cardiovasc Thorac Ann, 27(2), 87-92, 201902
  345. Metachronous Lung Cancer After Pleurectomy/Decortication, ANNALS OF THORACIC SURGERY, 107(1), E1-E3, 201901
  346. Prospective feasibility study of sealing pulmonary vessels with energy in lung surgery, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 157(1), 388-395, 201901
  347. Three-step surgical treatment of aortoesophageal fistula after thoracic endovascular aortic repair: A case report, INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 65, 221-224, 2019
  348. Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study, BMC CANCER, 18, 20181210
  349. Aminopeptidase N/CD13 as a potential therapeutic target in malignant pleural mesothelioma, EUROPEAN RESPIRATORY JOURNAL, 51(5), 20180501
  350. MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung, SCIENTIFIC REPORTS, 8, 20180109
  351. Increased risk of recurrence in resected EGFR-positive pN0M0 invasive lung adenocarcinoma, THORACIC CANCER, 9(12), 1594-1602, 201812
  352. Induction Chemoradiotherapy (50 Gy), Followed by Resection, for Stage IIIA-N2 Non-Small Cell Lung Cancer, ANNALS OF THORACIC SURGERY, 106(4), 1018-1024, 201810
  353. Thoracic and cardiovascular surgery in Japan during 2015: Annual report by The Japanese Association for Thoracic Surgery, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 66(10), 581-615, 201810
  354. Intratumoral heterogeneity on dedicated breast positron emission tomography predicts malignancy grade of breast cancer, BREAST CANCER RESEARCH AND TREATMENT, 171(2), 315-323, 201809
  355. The differences in histological changes among pulmonary vessels divided with an energy device, INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 27(3), 372-378, 201809
  356. Impact of Interval Between Neoadjuvant Chemoradiation and Surgery Upon Morbidity and Survival of Patients with Squamous Cell Carcinoma of Thoracic Esophagus, ANTICANCER RESEARCH, 38(9), 5239-5245, 201809
  357. Long-term results of neoadjuvant chemoradiotherapy using cisplatin and 5-fluorouracil followed by esophagectomy for resectable, locally advanced esophageal squamous cell carcinoma, JOURNAL OF RADIATION RESEARCH, 59(5), 616-624, 201809
  358. Segmentectomy Versus Lobectomy for Radiologically Pure Solid Clinical T1a-bN0M0 Lung Cancer, WORLD JOURNAL OF SURGERY, 42(8), 2493-2501, 201808
  359. Bronchoplasties at the Segmental Level, THORACIC SURGERY CLINICS, 28(3), 299-+, 201808
  360. Treatment Outcomes and Prognostic Factors After Recurrence of Esophageal Squamous Cell carcinoma, WORLD JOURNAL OF SURGERY, 42(7), 2190-2198, 201807
  361. Preoperative prediction of a pathologic complete response of esophageal squamous cell carcinoma to neoadjuvant chemoradiotherapy, SURGERY, 164(1), 40-48, 201807
  362. Evaluation of Prognostic Factors for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery, WORLD JOURNAL OF SURGERY, 42(5), 1496-1505, 201805
  363. Reassessment of Right Middle Lobe Lung Cancer: Comparison of Segments 4 and 5 Tumors, ANNALS OF THORACIC SURGERY, 105(5), 1543-1550, 201805
  364. Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma, MODERN PATHOLOGY, 31(5), 809-815, 201805
  365. A Multicenter Randomized Controlled Study of Paclitaxel plus Carboplatin versus Oral Uracil-Tegafur as the Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer, JOURNAL OF THORACIC ONCOLOGY, 13(5), 699-706, 201805
  366. A proposal for a comprehensive risk scoring system for predicting postoperative complications in octogenarian patients with medically operable lung cancer: JACS1303, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 53(4), 835-841, 201804
  367. Dedicated breast PET for detecting residual disease after neoadjuvant chemotherapy in operable breast cancer: A prospective cohort study, EJSO, 44(4), 444-448, 201804
  368. Management pathways for solitary pulmonary nodules, JOURNAL OF THORACIC DISEASE, 10, S860-S866, 201804
  369. Portable impulse-radar detector for breast cancer: a pilot study, JOURNAL OF MEDICAL IMAGING, 5(2), 201804
  370. Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-smallcell Lung Cancer Associated With Poor Prognosis, EBIOMEDICINE, 29, 112-127, 201803
  371. Utility of Survivin, BAP1, and Ki-67 immunohistochemistry in distinguishing epithelioid mesothelioma from reactive mesothelial hyperplasia, ONCOLOGY LETTERS, 15(3), 3540-3547, 201803
  372. Role of F-18-PET/CT in Predicting Prognosis of Patients With Breast Cancer After Neoadjuvant Chemotherapy, CLINICAL BREAST CANCER, 18(1), 45-52, 201802
  373. Postoperative complications and prognosis after lobar resection versus sublobar resection in elderly patients with clinical Stage I non-small-cell lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 53(2), 366-371, 201802
  374. A randomized Phase III trial of lobe-specific vs. systematic nodal dissection for clinical Stage I-II non-small cell lung cancer (JCOG1413), JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 48(2), 190-194, 201802
  375. Significance of lung biopsy for the definitive diagnosis of lung nodules in breast cancer patients, MOLECULAR AND CLINICAL ONCOLOGY, 8(2), 250-256, 201802
  376. Bevacizumab with Single-agent Chemotherapy in Previously Treated Non-squamous Non-small-cell Lung Cancer: Phase II Study, IN VIVO, 32(5), 1155-1160, 2018
  377. Which type of breast cancers is undetectable on ring-type dedicated breast PET?, CLINICAL IMAGING, 51, 186-191, 2018
  378. Therapeutic strategies and genetic profile comparisons in small cell carcinoma and large cell neuroendocrine carcinoma of the lung using next-generation sequencing, ONCOTARGET, 8(65), 108936-108945, 20171212
  379. Detectability of Breast Tumor by a Hand-held Impulse-Radar Detector: Performance Evaluation and Pilot Clinical Study, SCIENTIFIC REPORTS, 7, 20171127
  380. Differences in immune response to anesthetics used for day surgery versus hospitalization surgery for breast cancer patients, CLINICAL AND TRANSLATIONAL MEDICINE, 6, 20170914
  381. Gene expression profiling of idiopathic interstitial pneumonias (IIPs): identification of potential diagnostic markers and therapeutic targets, BMC MEDICAL GENETICS, 18, 20170818
  382. New noncontact sensor for detecting pulmonary tumors during video-assisted thoracic surgery, JOURNAL OF SURGICAL RESEARCH, 214, 62-68, 20170615
  383. Model of lung cancer surgery risk derived from a Japanese nationwide web-based database of 78 594 patients during 2014-2015, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 52(6), 1182-1189, 201712
  384. Clinicopathologic Features of Submucosal Esophageal Squamous Cell Carcinoma, ANNALS OF THORACIC SURGERY, 104(6), 1858-1864, 201712
  385. Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer, ANNALS OF THORACIC SURGERY, 104(6), 1896-1901, 201712
  386. Neoadjuvant and adjuvant therapy for Stage III non-small cell lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 47(12), 1112-1118, 201712
  387. Effects of Neoadjuvant Chemoradiotherapy on Pathological TNM Stage and Their Prognostic Significance for Surgically-treated Esophageal Squamous Cell Carcinoma, ANTICANCER RESEARCH, 37(10), 5639-5646, 201710
  388. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 154(3), 1089-+, 201709
  389. Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection?, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 65(9), 512-518, 201709
  390. Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid Mesothelioma by Transcriptome Microarray Analysis for Its Differentiation From Pulmonary Adenocarcinoma, AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 41(8), 1045-1052, 201708
  391. Clinical benefit of neoadjuvant chemoradiotherapy for the avoidance of pneumonectomy; assessment in 12 consecutive centrally located non-small cell lung cancers, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 65(7), 392-399, 201707
  392. Role of Postoperative C-Reactive Protein Levels in Predicting Prognosis After Surgical Treatment of Esophageal Cancer, WORLD JOURNAL OF SURGERY, 41(6), 1558-1565, 201706
  393. MUC4, a novel immunohistochemical marker identified by gene expression profiling, differentiates pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma, MODERN PATHOLOGY, 30(5), 672-681, 201705
  394. Utility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma, HISTOPATHOLOGY, 70(3), 375-384, 201702
  395. Is cancer history really an exclusion criterion for clinical trial of lung cancer ? Influence of gastrointestinal tract cancer history on the outcomes of lung cancer surgery, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 47(2), 145-156, 201702
  396. Preoperative predictors of distant recurrence in patients with clinical stage IA lung adenocarcinoma undergoing complete resection, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 47(2), 157-163, 201702
  397. Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 51(2), 218-222, 201702
  398. Limited resection for early-stage non-small cell lung cancer as function-preserving radical surgery: a review, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 47(1), 7-11, 201701
  399. CLINICAL AND MOLECULAR FEATURES OF RAPIDLY PROGRESSIVE CHRONIC HYPERSENSITIVITY PNEUMONITIS, SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 34(1), 48-57, 2017
  400. A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study), RESPIRATORY RESEARCH, 17, 20160722
  401. Bevacizumab beyond disease progression after first-line treatment with bevacizumab plus chemotherapy in advanced nonsquamous non-small cell lung cancer (West Japan Oncology Group 5910L): An open-label, randomized, phase 2 trial, CANCER, 122(7), 1050-1059, 20160401
  402. Clinical Significance of FDG-PET to Predict Pathologic Tumor Invasion and Lymph Node Metastasis of Superficial Esophageal Squamous Cell Carcinoma, ANNALS OF SURGICAL ONCOLOGY, 23(12), 4086-4092, 201611
  403. Prognostic significance of vascular invasion in intermediate-grade subtype of lung adenocarcinoma, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 46(11), 1015-1021, 201611
  404. Prognostic Role of Subtype Classification in Small-Sized Pathologic N0 Invasive Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 102(5), 1668-1673, 201611
  405. Ability of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography to Predict Outcomes of Neoadjuvant Chemoradiotherapy Followed by Surgical Treatment for Esophageal Squamous Cell Carcinoma, ANNALS OF THORACIC SURGERY, 102(4), 1132-1140, 201610
  406. Long-term results after 12-year follow-up of patients treated with whole-breast and boost irradiation after breast-conserving surgery, JAPANESE JOURNAL OF RADIOLOGY, 34(9), 595-604, 201609
  407. Application of Lepidic Component Predominance to Adjuvant Chemotherapy with Oral Fluoropyrimidines for Stage I Lung Adenocarcinoma, CLINICAL LUNG CANCER, 17(5), 433-440, 201609
  408. Severity of lung fibrosis affects early surgical outcomes of lung cancer among patients with combined pulmonary fibrosis and emphysema, MEDICINE, 95(29), 201607
  409. Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial), INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 21(3), 523-530, 201606
  410. EVALUATION OF MALIGNANCY GRADE OF BREAST CANCER USING PERFLUBUTANE-ENHANCED ULTRASONOGRAPHY, ULTRASOUND IN MEDICINE AND BIOLOGY, 42(5), 1049-1057, 201605
  411. Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 46(4), 303-309, 201604
  412. Enhanced gefitinib-induced repression of the epidermal growth factor receptor pathway by ataxia telangiectasia-mutated kinase inhibition in non-small-cell lung cancer cells, CANCER SCIENCE, 107(4), 444-451, 201604
  413. Complete transection of the left main bronchus caused by blunt thoracic trauma in a child treated by bronchoplasty and lung parenchyma preservation, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 64(2), 113-115, 201602
  414. Negative prognostic influence of micropapillary pattern in stage IA lung adenocarcinoma, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 49(1), 293-299, 201601
  415. Use of Anti-Noxa Antibody for Differential Diagnosis between Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia, PATHOBIOLOGY, 83(1), 33-40, 2016
  416. Role of definitive chemoradiotherapy using docetaxel and 5-fluorouracil in patients with unresectable locally advanced esophageal squamous cell carcinoma: a phase II study, DISEASES OF THE ESOPHAGUS, 29(8), 1115-1120, 2016
  417. Feasibility and efficacy of salvage lung resection after definitive chemoradiation therapy for Stage III non-small-cell lung cancer., Interactive cardiovascular and thoracic surgery, 23(6), 895-901, 2016
  418. Surgical Resection of Thoracic Esophageal Cancer with Interstitial Lung Disease: A Case Report., Hiroshima journal of medical sciences, 65(1), 19-23, 2016
  419. Completion lobectomy after radical segmentectomy for pulmonary malignancies., Asian cardiovascular & thoracic annals, 24(5), 450-454, 2016
  420. Randomized Phase II Study of Adjuvant Chemotherapy with Long-term S-1 versus Cisplatin+S-1 in Completely Resected Stage II-IIIA Non-Small Cell Lung Cancer, CLINICAL CANCER RESEARCH, 21(23), 5245-5252, 20151201
  421. Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma., Annals of thoracic surgery, 20150820
  422. The intracellular domain of cell adhesion molecule 1 is present in emphysematous lungs and induces lung epithelial cell apoptosis, JOURNAL OF BIOMEDICAL SCIENCE, 22, 20150811
  423. Randomized phase II study of adjuvant chemotherapy with long-term S-1 versus cisplatin+S-1 in completely resected stage II-IIIA non-small cell lung cancer., Clinical cancer research, 20150807
  424. Increased ectodomain shedding of cell adhesion molecule 1 as a cause of type II alveolar epithelial cell apoptosis in patients with idiopathic interstitial pneumonia, RESPIRATORY RESEARCH, 16, 20150801
  425. Surgical Outcomes of Lung Cancer in Patients with Combined Pulmonary Fibrosis and Emphysema., Annals of surgical oncology, 20150509
  426. Negative prognostic influence of micropapillary pattern in stage IA lung adenocarcinoma., European journal of cardio-thoracic surgery, 20150311
  427. Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 100(6), 2079-2086, 201512
  428. Surgical Outcomes of Lung Cancer in Patients with Combined Pulmonary Fibrosis and Emphysema, ANNALS OF SURGICAL ONCOLOGY, 22, S1371-S1379, 201512
  429. Association between [F-18]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1 alpha and glucose transporter 1 in non-small cell lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 45(12), 1154-1161, 201512
  430. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma., Lung Cancer, 90(2), 199-204, 201511
  431. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma, LUNG CANCER, 90(2), 199-204, 201511
  432. Prognostic signature of protocadherin 10 methylation in curatively resected pathological stage I non-small-cell lung cancer, CANCER MEDICINE, 4(10), 1536-1546, 201510
  433. Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypes, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 45(8), 767-773, 201508
  434. Prediction of lymph node status in clinical stage IA squamous cell carcinoma of the lung, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 47(6), 1022-1026, 201506
  435. Results of Neoadjuvant Chemoradiotherapy With Docetaxel and 5-Fluorouracil Followed by Esophagectomy to Treat Locally Advanced Esophageal Cancer, ANNALS OF THORACIC SURGERY, 99(6), 1887-1893, 201506
  436. Methylated DLX4 Predicts Response to Pathologic Stage I Non-Small Cell Lung Cancer Resection, ANNALS OF THORACIC SURGERY, 99(5), 1746-1754, 201505
  437. The Efficacy and Safety of Preoperative Chemotherapy With Triweekly Abraxane and Cyclophosphamide Followed by 5-Fluorouracil, Epirubicin, and Cyclophosphamide Therapy for Resectable Breast Cancer: A Multicenter Clinical Trial, CLINICAL BREAST CANCER, 15(2), 110-116, 201504
  438. Histologic changes associated with the use of fibrinogen- and thrombin-impregnated collagen in the prevention of pulmonary air leakage, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 149(4), 982-988, 201504
  439. What are the radiologic findings predictive of indolent lung adenocarcinoma?, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 45(4), 367-372, 201504
  440. Surgical outcomes of non-small-cell lung carcinoma in patients previously treated for gastric cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 47(4), 648-652, 201504
  441. Emergency escape surgery for a gastro-bronchial fistula with respiratory failure that developed after esophagectomy, Surgery Today, 45(3), 369-373, 201503
  442. Comparison of Malignant Grade Between Pure and Partially Invasive Types of Early Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 99(3), 956-960, 201503
  443. Prognostic impact of lymphatic invasion for pathological stage I squamous cell carcinoma of the lung, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 63(3), 153-158, 201503
  444. Utility of F-18 FDG-PET/CT for predicting prognosis of luminal-type breast cancer, BREAST CANCER RESEARCH AND TREATMENT, 150(1), 209-217, 201502
  445. The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling, NATURE CELL BIOLOGY, 17(1), 81-+, 201501
  446. Effects of neoadjuvant chemoradiotherapy on postoperative morbidity and mortality associated with esophageal cancer, DISEASES OF THE ESOPHAGUS, 28(4), 358-364, 2015
  447. The Difference in Maximum Standardized Uptake Value among Lung Adenocarcinomas Located at the Upper and Lower Zone on PET/CT, RESPIRATION, 90(4), 293-298, 2015
  448. Complex permittivities of breast tumor tissues obtained from cancer surgeries, APPLIED PHYSICS LETTERS, 104(25), 20140623
  449. Prognosis of Lung Cancer Patients with a Past History of Colorectal Cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 44(11), 1088-1095, 201411
  450. Role of FDG-PET/CT in Prediction of Underestimation of Invasive Breast Cancer in Cases of Ductal Carcinoma In Situ Diagnosed at Needle Biopsy, CLINICAL BREAST CANCER, 14(5), 358-364, 201410
  451. Propensity score-matched analysis of adjuvant chemotherapy for stage I non-small cell lung cancer, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 148(4), 1179-1185, 201410
  452. Segmentectomy for clinical stage IA lung adenocarcinoma showing solid dominance on radiology, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 46(4), 637-642, 201410
  453. Three models for predicting the risk of non-sentinel lymph node metastasis in Japanese breast cancer patients, BREAST CANCER, 21(5), 571-575, 201409
  454. Hemoglobin Level Influences Tumor Response and Survival After Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma, WORLD JOURNAL OF SURGERY, 38(8), 2046-2051, 201408
  455. Prediction for prognosis of resected pT1a-lbN0M0 adenocarcinoma based on tumor size and histological status: Relationship of TNM and IASLC/ATS/ERS classifications, LUNG CANCER, 85(2), 270-275, 201408
  456. Role of Positron Emission Tomography/Computed Tomography Findings for Adjuvant Chemotherapy Indications in Stage T1b-2aN0M0 Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 98(2), 417-423, 201408
  457. Role of lymphatic invasion in the prognosis of patients with clinical node-negative and pathologic node-positive lung adenocarcinoma, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 147(6), 1820-1826, 201406
  458. Sublobar Resection for Lung Adenocarcinoma Meeting Node-Negative Criteria on Preoperative Imaging, ANNALS OF THORACIC SURGERY, 97(5), 1701-1707, 201405
  459. Increased ectodomain shedding of lung epithelial cell adhesion molecule 1 as a cause of increased alveolar cell apoptosis in emphysema, THORAX, 69(3), 223-231, 201403
  460. Segmentectomy versus lobectomy for clinical stage IA lung adenocarcinoma., Annals of cardiothoracic surgery, 3(2), 153-159, 201403
  461. alpha-Parvin, a pseudopodial constituent, promotes cell motility and is associated with lymph node metastasis of lobular breast carcinoma, BREAST CANCER RESEARCH AND TREATMENT, 144(1), 59-69, 201402
  462. Esophageal Bypass Operation Prior to Definitive Chemoradiotherapy in Advanced Esophageal Cancer With Tracheobronchial Invasion, ANNALS OF THORACIC SURGERY, 97(1), 290-295, 201401
  463. Appropriate Sublobar Resection Choice for Ground Glass Opacity-Dominant Clinical Stage IA Lung Adenocarcinoma Wedge Resection or Segmentectomy, CHEST, 145(1), 66-71, 201401
  464. Lung Abscess Presenting as Tension Pyopneumothorax in a Gastrointestinal Cancer Patient, ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 20, 478-481, 2014
  465. Methylation of breast cancer susceptibility gene 1 (BRCA1) predicts recurrence in patients with curatively resected stage I nonsmall cell lung cancer, CANCER, 119(4), 792-798, 20130215
  466. Involvement of homologous recombination in the synergism between cisplatin and poly (ADP-ribose) polymerase inhibition, CANCER SCIENCE, 104(12), 1593-1599, 201312
  467. Prognostic Role of Positron Emission Tomography and High-Resolution Computed Tomography in Clinical Stage IA Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 96(6), 1958-1965, 201312
  468. Classifications of N2 None-Small-Cell Lung Cancer Based on the Number and Rate of Metastatic Mediastinal Lymph Nodes, CLINICAL LUNG CANCER, 14(6), 651-657, 201311
  469. Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer - Usefulness for malignant grade of triple-negative breast cancer, BREAST, 22(5), 958-963, 201310
  470. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 146(3), 580-585, 201309
  471. Solid tumor size on high-resolution computed tomography and maximum standardized uptake on positron emission tomography for new clinical T descriptors with T1 lung adenocarcinoma, ANNALS OF ONCOLOGY, 24(9), 2376-2381, 201309
  472. Role of maximum standardized uptake value in fluorodeoxyglucose positron emission tomography/computed tomography predicts malignancy grade and prognosis of operable breast cancer: a multi-institute study, BREAST CANCER RESEARCH AND TREATMENT, 141(2), 269-275, 201309
  473. Treatment Outcomes and Prognostic Factors for Thoracic Esophageal Cancer with Clinical Evidence of Adjacent Organ Invasion, ANTICANCER RESEARCH, 33(8), 3495-3502, 201308
  474. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: Propensity score-matched analysis in a multicenter study, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 146(2), 358-364, 201308
  475. Radical Sublobar Resection for Small-Diameter Lung Cancers, THORACIC SURGERY CLINICS, 23(3), 301-+, 201308
  476. Solid tumors versus mixed tumors with a ground-glass opacity component in patients with clinical stage IA lung adenocarcinoma: Prognostic comparison using high-resolution computed tomography findings, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 146(1), 17-23, 201307
  477. Decreased FANCJ caused by 5FU contributes to the increased sensitivity to oxaliplatin in gastric cancer cells, GASTRIC CANCER, 16(3), 345-354, 201307
  478. Involvement of ribonucleotide reductase-M1 in 5-fluorouracil-induced DNA damage in esophageal cancer cell lines, INTERNATIONAL JOURNAL OF ONCOLOGY, 42(6), 1951-1960, 201306
  479. A Feasibility Study of Induction Pemetrexed Plus Cisplatin Followed by Pleurectomy/Decortication Aimed at Macroscopic Complete Resection for Malignant Pleural Mesothelioma, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 43(5), 575-578, 201305
  480. Subtyping Lung Adenocarcinoma According to the Novel 2011 IASLC/ATS/ERS Classification Correlation with Patient Prognosis, THORACIC SURGERY CLINICS, 23(2), 179-+, 201305
  481. Airway Stenting for Tracheal Obstruction Due to Lymph Node Metastasis of Hepatocellular Carcinoma, ANTICANCER RESEARCH, 33(4), 1761-1764, 201304
  482. Prognostic significance of metabolic response by positron emission tomography after neoadjuvant chemotherapy for resectable malignant pleural mesothelioma, ANNALS OF ONCOLOGY, 24(4), 1005-1010, 201304
  483. Metabolomic analysis of dynamic response and drug resistance of gastric cancer cells to 5-fluorouracil, ONCOLOGY REPORTS, 29(3), 925-931, 201303
  484. Technical Feasibility and Cosmetic Advantage of Hybrid Endoscopy-Assisted Breast-Conserving Surgery for Breast Cancer Patients, JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES, 23(2), 91-99, 201302
  485. Leiomyosarcoma of the sigmoid colon with multiple liver metastases and gastric cancer: a case report, BMC GASTROENTEROLOGY, 12, 20120731
  486. Upregulation of Notch2 and Six1 Is Associated with Progression of Early- Stage Lung Adenocarcinoma and a More Aggressive Phenotype at Advanced Stages, CLINICAL CANCER RESEARCH, 18(4), 945-955, 20120215
  487. Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer, INTERNATIONAL JOURNAL OF CANCER, 130(2), 377-387, 20120115
  488. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 144(6), 1365-1371, 201212
  489. Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas, ANNALS OF ONCOLOGY, 23(12), 3129-3137, 201212
  490. Advanced esophageal cancer with an esophago-bronchial fistula successfully treated by chemoradiotherapy following esophageal bypass surgery: report of a case, SURGERY TODAY, 42(11), 1088-1090, 201211
  491. Non-small-cell lung cancer prognosis using carcinoembryonic antigen levels in pleural lavage fluid, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 42(5), E96-E101, 201211
  492. Novel application for pseudopodia proteomics using excimer laser ablation and two-dimensional difference gel electrophoresis, LABORATORY INVESTIGATION, 92(9), 1374-1385, 201209
  493. Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer, CANCER CHEMOTHERAPY AND PHARMACOLOGY, 69(6), 1499-1505, 201206
  494. Airway Stenting for Malignant Respiratory Complications in Esophageal Cancer, ANTICANCER RESEARCH, 32(5), 1785-1790, 201205
  495. Laparoscopic Thoracic Duct Clipping for Persistent Chylothorax After Extrapleural Pneumonectomy, ANNALS OF THORACIC SURGERY, 93(5), E131-E132, 201205
  496. Fibrinogen/thrombin-based collagen fleece (TachoComb((R))) promotes regeneration in pulmonary arterial injury, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 41(4), 926-932, 201204
  497. Esophageal reconstruction using the terminal ileum and right colon in esophageal cancer surgery, SURGERY TODAY, 42(4), 342-350, 201204
  498. Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: A multicenter study, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 143(3), 607-612, 201203
  499. Memorial Sloan-Kettering Cancer Center Nomogram to predict the risk of non-sentinel lymph node metastasis in Japanese breast cancer patients, SURGERY TODAY, 42(3), 245-249, 201202
  500. Radical hybrid video-assisted thoracic segmentectomy: long-term results of minimally invasive anatomical sublobar resection for treating lung cancer, INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 14(1), 5-11, 201201
  501. Interferon (Alpha, Beta and Omega) Receptor 2 Is a Prognostic Biomarker for Lung Cancer, PATHOBIOLOGY, 79(1), 24-33, 2012
  502. Cathepsin D as a potential prognostic marker for lung adenocarcinoma, PATHOLOGY RESEARCH AND PRACTICE, 208(9), 534-540, 2012
  503. A case of HER-2-positive recurrent breast cancer showing a clinically complete response to trastuzumab-containing chemotherapy after primary treatment of triple-negative breast cancer, WORLD JOURNAL OF SURGICAL ONCOLOGY, 9, 20111107
  504. Steroid receptor expression in thymomas and thymic carcinomas., Cancer, 117(19), 4396-4405, 20111001
  505. Steroid Receptor Expression in Thymomas and Thymic Carcinomas, CANCER, 117(19), 4396-4405, 20111001
  506. Difference in prognostic significance of maximum standardized uptake value on [18F]-fluoro-2-deoxyglucose positron emission tomography between adenocarcinoma and squamous cell carcinoma of the lung., Jpn J Clin Oncol, 41(7), 890-896, 20110701
  507. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma., Jpn J Thorac Cardiovasc Surg, 141(6), 1384-1391, 20110601
  508. Advanced esophageal cancer with situs inversus totalis successfully treated with chemoradiotherapy followed by esophagectomy: case report, Hiroshima J Med Sci, 60(1), 21-4, 20110601
  509. Successful management of multiple esophagorespiratory fistulas using two types of stent: report of a case., Surg Today, 41(4), 560-2, 20110401
  510. Hybrid video-assisted thoracic surgery basilar (S9-10) segmentectomy., Semin Thorac Cardiovasc Surg, 23(1), 73-77, 20110401
  511. Advanced esophageal cancer with situs inversus totalis successfully treated with chemoradiotherapy followed by esophagectomy: case report., Hiroshima J Med Sci, 60(1), 21-24, 20110301
  512. Difference in Prognostic Significance of Maximum Standardized Uptake Value on [18F]-Fluoro-2-Deoxyglucose Positron Emission Tomography Between Adenocarcinoma and Squamous Cell Carcinoma of the Lung, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 41(7), 890-896, 201107
  513. Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 141(6), 1384-1391, 201106
  514. Successful management of multiple esophagorespiratory fistulas using two types of stent: Report of a case, SURGERY TODAY, 41(4), 560-562, 201104
  515. Advantage of absorbable suture material for pulmonary artery ligation., Gen Thorac Cardiovasc Surg, 58(10), 511-5, 20101001
  516. Suggestive synchronous triple squamous cell carcinoma of the lung in the same lobe., Gen Thorac Cardiovasc Surg, 58, 427-30, 20100801
  517. Value of integrated positron emission tomography revised using a phantom to evaluate malignancy grade of lung adenocarcinoma: a multicenter study., Cancer, 111, 3170-7, 20100701
  518. Value of Integrated Positron Emission Tomography Revised Using a Phantom Study to Evaluate Malignancy Grade of Lung Adenocarcinoma A Multicenter Study, CANCER, 116(13), 3170-3177, 20100701
  519. Rapamycin enhances chemotherapy-induced cytotoxicity by inhibiting the expressions of TS and ERK in gastric cancer cells., Int J Cancer, 126(11), 2716-25, 20100601
  520. Impact of positive pleural lavage cytology on survival in patients having lung resection for non-small-cell lung cancer: An international individual patient data meta-analysis., J Thorac Cardiovasc Surg, 139(6), 1441-6, 20100601
  521. Impact of positive pleural lavage cytology on survival in patients having lung resection for non-small-cell lung cancer: An international individual patient data meta-analysis., Jpn J Thorac Cardiovasc Surg, 139(6), 1441-6, 20100601
  522. Rapamycin enhances chemotherapy-induced cytotoxicity by inhibiting the expressions of TS and ERK in gastric cancer cells, INTERNATIONAL JOURNAL OF CANCER, 126(11), 2716-2725, 20100601
  523. Surgical treatment of clinical N1 non-small cell lung cancer: ongoing controversy over diagnosis and prognosis., Surg Today, 40(5), 428-32, 20100501
  524. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L)., Jpn J Clin Oncol, 40(3), 271-4, 20100301
  525. Phase I trial of oxaliplatin plus S-1 chemotherapy in patients with metastatic colorectal cancer., Oncol Lett, 1(1), 95-98, 20100101
  526. Surgical treatment of clinical N1 non-small cell lung cancer: Ongoing controversy over diagnosis and prognosis, SURGERY TODAY, 40(5), 428-432, 201005
  527. A Phase III Randomized Trial of Lobectomy Versus Limited Resection for Small-sized Peripheral Non-small Cell Lung Cancer (JCOG0802/WJOG4607L), JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 40(3), 271-274, 201003
  528. Phase I trial of oxaliplatin plus S-1 chemotherapy in patients with metastatic colorectal cancer, ONCOLOGY LETTERS, 1(1), 95-98, 2010
  529. Invited Commentary for Limited resection for noninvasive bronchioloalveolar carcinoma diagnosed by intraoperative pathologic examination., Ann Thorac Surg, 88(4), 1111, 20091001
  530. Short disease-free interval is a significant risk factor for intrapulmonary recurrence after resection of pulmonary metastases in colorectal cancer., Colorectal Dis, 12((7 online)), e68-75, 20090701
  531. Skin tube reconstruction for esophageal defect due to postoperative complication., Ann Thorac Surg, 87, 1605-07, 20090501
  532. Skin tube reconstruction for esophageal defect due to postoperative complication, Ann Thorac Surg, 87(5), 1605-7, 20090501
  533. Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer, Cancer Immunol Immunother, 39(3), 441-7, 20090301
  534. A Feasibility Study of Induction Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Postoperative Hemithoracic Radiation for Malignant Pleural Mesothelioma., Jpn J Clin Oncol, 39(3), 186-8, 20090301
  535. Induction of gamma delta T cells using zoledronate plus interleukin-2 in patients with metastatic cancer., Hiroshima J Med Sci, 58(1), 37-44, 20090301
  536. Targeting of CD4+CD25high cells while preserving CD4+CD25low cells with low-dose chimeric anti-CD2 antibody in adoptive immunotherapy of cancer., Int J Oncol, 34(2), 563-72, 20090201
  537. Invasive ductal carcinoma of the pancreas showing exophytic growth., Hepatobiliary Pancreat Dis Int, 8(1), 97-102, 20090201
  538. Targeting of CD4+CD25high cells while preserving CD4+CD25low cells with low-dose chimeric anti-CD25 antibody in adoptive immunotherapy of cancer, Int J Oncol, 34(2), 563-72, 20090201
  539. A Feasibility Study of Induction Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Postoperative Hemithoracic Radiation for Malignant Pleural Mesothelioma, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 39(3), 186-188, 200903
  540. Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer, CANCER IMMUNOLOGY IMMUNOTHERAPY, 58(3), 441-447, 200903
  541. Targeting of CD4(+)CD25(high) cells while preserving CD4(+)CD25(low) cells with low-dose chimeric anti-CD25 antibody in adoptive immunotherapy of cancer, INTERNATIONAL JOURNAL OF ONCOLOGY, 34(2), 563-572, 200902
  542. Invasive ductal carcinoma of the pancreas showing exophytic growth, HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 8(1), 97-102, 200902
  543. Decreased orotate phosphoribosyltransferase activity produces 5-fluorouracil resistance in a human gastric cancer cell line., Oncol Rep, 20(6), 1545-1551, 20081201
  544. Expression of orotate phosphoribosyltransferase in colorectal carcinoma: an immunohistochemical analysis in several components of neoplastic lesions., Oncology Rep, 20(5), 1005-1011, 20081101
  545. Expression of orotate phosphoribosyltransferase in colorectal carcinoma: an immunohistochemical analysis in several components of neoplastic lesions, Oncol Rep, 20(5), 1005-11, 20081101
  546. A randomised phase II trial of preoperative chemotherapy of cisplatin-docetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG 0204), BRITISH JOURNAL OF CANCER, 99(6), 852-857, 20080909
  547. A randomised phase II trial of preoperative chemotherapy of cisplatin-docetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer results of a Japan Clinical Oncology Group trial (JCOG 0204)., Br J Cancer, 99(6), 20080901
  548. Dihydropyrimidine dehydrogenase and orotate phosphoribosyltransferase in esophageal cancer patients: Correlation with clinicopathological factors and prognosis, Mol Med Report, 1(5), 713-9, 20080901
  549. A feasibility study of postoperative adjuvant therapy of carboplatin and weekly paclitaxel for completely resected non-small cell lung cancer., J Thorac Oncol., 3(6), 612-616, 20080601
  550. Expression of cell adhesion molecule 1 in malignant pleural mesothelioma as a cause of efficient adhesion and growth on mesothelium., Lab Invest., 88(5), 504-514, 20080501
  551. Dose-finding study of anti-CD25 antibody for targeting regulatory T cells in locoregional immunotherapy of malignant effusion., Hiroshima J Med Sci., 57(1), 37-46, 20080501
  552. Radical sublobar resection for lung cancer., Gen Thorac Cardiovasc Surg., 56(4), 151-7, 20080401
  553. Radical surgery for malignant pleural mesothelioma: results and prognosis., Interact Cardiovasc Thorac Surg., 7(1), 102-106, 20080201
  554. Decreased orotate phosphoribosyltransferase activity produces 5-fluorouracil resistance in a human gastric cancer cell line, ONCOLOGY REPORTS, 20(6), 1545-1551, 200812
  555. Expression of orotate phosphoribosyltransferase in colorectal carcinoma: An immunohistochemical analysis in several components of neoplastic lesions, ONCOLOGY REPORTS, 20(5), 1005-1011, 200811
  556. Functional inactivation of CD4+CD25(high) regulatory T cells using low dose human/mouse chimeric anti-CD25 monoclonal antibody enhanced lymphokine-activated killer cells activity, TARGETED ONCOLOGY, 3(4), 227-234, 200810
  557. A feasibility study of postoperative adjuvant therapy of carboplatin and weekly paclitaxel for completely resected non-small cell lung cancer, JOURNAL OF THORACIC ONCOLOGY, 3(6), 612-616, 200806
  558. Expression of cell adhesion molecule 1 in malignant pleural mesothelioma as a cause of efficient adhesion and growth on mesothelium, LABORATORY INVESTIGATION, 88(5), 504-514, 200805
  559. Dihydropyrimidine dehydrogenase and orotate phosphoribosyltransferase in esophageal cancer patients: Correlation with clinicopathological factors and prognosis, MOLECULAR MEDICINE REPORTS, 1(5), 713-719, 2008
  560. Pleomorphic carcinoma of the lung., Jpn J Thorac Cardiovasc Surg, 134, 399-404, 20070801
  561. Associations among bronchioloalveolar carcinoma component, positron emission tomographic, computed tomographic findings and malignant behavior in small lung adenocarcinomas, J. Thorac Cardiovasc Surg, 20070401
  562. A novel video-assisted anatomical segmentectomy technique-Selective segmental inflation via bronchofiberoptic jet followed by cautery cutting-, J. Thorac Cardiovasc Surg, 133, 753-758, 20070401
  563. Novel marker D2-40, combined with calretinin, CEA and TTF-1: An optimal set of immunodiagnostic markers for pleural mesothelioma, Cancer, 109(5), 933-938, 20070401
  564. Novel marker D2-40, combined with calretinin, CEA and TTF-1: An optimal set of immunodiagnostic markers for pleural mesothelioma., Cancer, 109(5), 933-938, 20070301
  565. Pleomorphic carcinoma of the lung: A surgical outcome, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 134(2), 399-404, 200708
  566. Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 133(6), 1448-1454, 200706
  567. Radical sublobar resection for small-sized non-small cell lung cancer: A multicenter study, J. Thorac Cardiovasc Surg, 132, 769-775, 20060401
  568. Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer, Ann Thorac Surg, 81, 1028-1032, 20060401
  569. Carbon monoxide rescues ischemic lungs by interrupting MAPK-driven expression of early growth response 1 gene and its downstream target genes., Proc. Natl. Acad. Sci. USA, 103(13), 5191-5196, 20060401
  570. Bronchoplasty for bronchial carcinoid tumor without removing lung parenchyma., Jpn J Thorac Cardiovasc Surg, 54(8), 345-347, 20060401
  571. Carbon monoxide rescues ischemic lung by interrupting MAPK-driven expression of early growth response 1 gene and its downstream target genes., Proccding of the National Academy of Sciences of the United States of America, 103(13), 5191-5196, 20060328
  572. Hybrid surgical approach of video-assisted minithoracotomy for lung cancer -Significance of direct visualization on quality of surgery-, Chest, 128(4), 2629-2701, 20050401
  573. Border between N1 and N2 stations in lung carcinoma: Lessons from lymph node metastatic patterns of lower lobe tumors, J. Thorac Cardiovasc Surg, 129(4), 825-830, 20050401
  574. Effect of tumor size on prognosis in non-small cell lung cancer:The role of segmentectomy as a type of lesser resection, J. Thorac Cardiovasc Surg, 129(1), 87-93, 20050401
  575. Influence of ischemic injury on vein graft remodeling: Role of cyclic adenosine monophosphate second messenger pathway in enhanced vein graft preservation, J. Thorac Cardiovasc Surg, 129, 129-137, 20050401
  576. Increased expression of connexin 26 in the invasive component of lung squamous cell carcinoma: Significant correlation with poor prognosis, Cancer lett., 234, 239-248, 20050401
  577. Functional advantage following radical segmentectomy over lobectomy for lung cancer, Ann Thorac Surg, 80(6), 2041-2045, 20050401
  578. Complications and outcomes after pulmonary resection for cancer in patients 80 to 89 years of age., Eur J Cardiothorac Surg, 28(3), 380-383, 20050401
  579. Sleeve segmentectomy for non-small cell lung carcinoma, J. Thorac Cardiovasc Surg, 128(3), 420-424, 20040401
  580. Effect of histologic type and smoking status on the interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma, Ann Thorac Surg, 78, 1004-1009, 20040401
  581. Evolution of surgical outcomes for non-small cell lung cancer:Time trends in 1465 consecutive patients subjected to a complete resection, Ann Thorac Surg, 77, 1926-1930, 20040401
  582. Correlation between computed tomographic findings, bronchioloalveolar carcinoma component and the biologic behavior of small-sized lung adenocarcinomas, J. Thorac Cardiovasc Surg, 127, 857-861, 20040401
  583. Cloning of a soluble isoform of the SgIGSF adhesion molecule that binds the extracellular domain of the membrane-bound isoform, Oncogene, 23, 5687-5692, 20040401
  584. Management of Air Leak after Pulmonary Resection, Jpn J Thorac Cardiovasc Surg, 52, 292-295, 20040401
  585. PKCbeta regulates ischemia/reperfusion injury in the lung, J. Clin. Invest., 113, 1615-1623, 20040401
  586. Resection of chest wall invasion in patients with non-small cell lung cancer, Eur J Cardiothorac Surg, 26(6), 1200-1204, 20040401
  587. PKCbeta regulates ischemia/reperfusion injury in the lung., The Journal of clinical investigation, 113(11), 1615-1623, 200406
  588. Discrepancy of computed tomographic image between lung and mediastinal windows as a prognostic implication in small lung adenocarcinoma, Ann Thorac Surg, 76, 1828-1832, 20030401
  589. Characteristics and prognosis of patients after resection of non-small cell lung carcinoma measuring 2 cm or less in greatest dimension, Cancer, 98(3), 535-541, 20030401
  590. Pleural lavage cytology in non-small cell lung cancer: Lessons from 1,000 consecutive resections, J. Thorac Cardiovasc Surg, 126(6), 1911-1915, 20030401
  591. Long-term survival and prognostic factors of 5-year survivorswith complete resection of non-small cell lung carcinoma, J. Thorac Cardiovasc Surg, 126(2), 558-562, 20030401
  592. Clinical implication and prognostic significance of the tumor-suppressor TSLC1 gene detected in adenocarcinomas of the lung, Cancer, 98, 1002-1007, 20030401
  593. Peroxisome proliferator-activated receptor-{gamma} (PPAR-{gamma}) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets, FASEB J., 16(14), 1861-1868, 20020401
  594. Transcriptional Control of Cardiac Allograft Vasculopathy by Early Growth Response Gene-1 (Egr-1), Circ Res, 91(2), 135-142, 20020401
  595. Extinguishing Egr-1-dependent inflammatory and thrombotic cascades after lung transplantation, FASEB J., 15(14), 2757-2759, 20010401
  596. Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller ?, Ann Thorac Surg, 71(3), 956-960, 20010401
  597. Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy, J. Thorac Cardiovasc Surg, 119, 814-819, 20000401
  598. Induction therapy for non-small cell lung cancer with involved mediastinal nodes in multiple stations, Chest, 118(1), 123-128, 20000401
  599. Surgical Treatment for Chronic Pleural Empyema, Surg Today, 30(6), 506-510, 20000401
  600. Multiple Primary Lung Carcinomas : Letter to Editor (Reply), J. Thorac Cardiovasc Surg, 119(4), 814-819, 20000401
  601. A role for heterologous gap junctions between melanoma and endothelial cells in metastasis, J. Clin. Invest., 105, 1189-1197, 20000401
  602. A role for heterologous gap junctions between melanoma and endothelial cells in metastasis., The Journal of clinical investigation, 105(9), 1189-1197, 200005
  603. Extended sleeve lobectomy for lung cancer: the avoidance of pneumonectomy, J. Thorac Cardiovasc Surg, 118(4), 710-713, 19990401
  604. How should interlobar pleural invasion be classified? Prognosis of resected T3 non-small cell lung cancer?, Ann Thorac Surg, 68(6), 2049-2052, 19990401
  605. Multiple Primary Lung Carcinomas : Letter to Editor (Reply), J. Thorac Cardiovasc Surg, 117(2), 405-406, 19990401
  606. Evaluation of TNM Classification for Lung Carcinoma with Ipsilateral Intrapulmonary Metastasis, Ann Thorac Surg, 68(2), 326-330, 19990401
  607. Prognosis of Completely Resected pN2 Non-Small Cell Lung Carcinomas: What is the Significant Node that Affects Survival?, J. Thorac Cardiovasc Surg, 118(2), 270-275, 19990401
  608. Right Upper and Middle Sleeve Bilobectomy with Atypical Pulmonary Arterioplasty, Ann Thorac Cardiovase Surg, 47, 121-123, 19990401
  609. Role of Pleural Lavage Cytology Before Resection for Primary Lung Carcinoma, Ann Surg, 229(4), 579-584, 19990401
  610. Usefulness of cardiopulmonary bypass in reconstruction of inferior vena cava occupied by renal cell carcinoma tumor thrombus, Angiology, 50, 47-53, 19990401
  611. Proposal for Reasonable Mediastinal Lymphadenectomy in Bronchogenic Carcinomas: Role of Subcarinal Nodes in Selective Dissection, J. Thorac Cardiovasc Surg, 116(6), 949-953, 19980401
  612. Two cases of synchronous multiple thymoma, Surg Today, 28, 1323-1325, 19980401
  613. Operative Approach for Multiple Primary Lung Carcinomas, J. Thorac Cardiovasc Surg, 115(4), 836-840, 19980401
  614. Omentopexy for anastomotic dehiscence after tracheal sleeve pneumonectomy, Thorac Cardiovasc Surgeon, 45(3), 144-145, 19970401
  615. Single Lung Transplantation for Canine Pulmonary Hypertension, J. Heart Lung Transplant., 16(5), 532-537, 19970401
  616. Sleeve lobectomy for lung carcinoma in a patient with muscular dystrophy, Thorac Cardiovasc Surgeon, 44(5), 264-265, 19960401
  617. Right ventricular ejection fraction in the preoperative risk evaluation of candidates for pulmonary resection, J. Thorac Cardiovasc Surg, 112, 364-370, 19960401
  618. Efficacy of oxygenated University of Wisconsin solution containing endothelin-A receptor antagonist in twenty-four-hour heart preservation, J. Heart Lung Transplant., 15, 475-484, 19960401
  619. Contribution of Endothelin-1 to Warm Ischemia/Reperfusion Injury of the Rat Lung, Am J Respir Crit Care Med, 152(6), 2105-2110, 19950401
  620. Establishment Canine Pulmonary Hypertension with Dehydromonocrotaline: Importance of a Larger Animal Model for Lung Transplantation, Transplantation, 60(1), 9-13, 19950401
  621. Role of Endothelin-1 in Beagles with Dehydromonocrotaline-Induced Pulmonary Hypertension, Circulation, 92(1), 114-119, 19950401
  622. Endothelin Receptor Antagonists in a Beagle Model of Pulmonary Hypertension. Contribution to Possible Potential Therapy?, J Am Coll Cardiol, 25(5), 1213-1217, 19950401
  623. A Dehydromonocrotaline-induced Pulmonary Hypertension Model in the Beagle., J. Thorac Cardiovasc Surg, 110(2), 546-547, 19950401
  624. ★, Simultaneous patch closure of an atrial septal defect and pancreaticoduodenectomy for chronic pancreatitis., Eur J Surg, 161(4), 295-297, 19950401
  625. Successful 24-hour rabbit heart preservation by hypothermic continuous coronary microperfusion with oxygenated University of Wisconsin Solution, Ann Thorac Surg, 60, 1723-1728, 19950401
  626. ★, Right ventricular dysfunction after major pulmonary resection, J. Thorac Cardiovasc Surg, 108(3), 503-511, 19940401
  627. ★, Cervicothoracic vagal neurilemoma, Surgery Today, 24(2), 183-186, 19940401
  628. ★, Simultaneous occurrence of three primary lung cancers, Chest, 105(2), 631-632, 19940401
  629. ★, The unusual development of empyema with multiple alveolobronchiolar fistulae 8 years after non-curative resection and radiation for lung cancer, Surgery Today, 23(12), 1085-1088, 19930401
  630. Successful resection of a recurrent leiomyosarcoma of the pulmonary trunk, Ann Thorac Surg, 55, 1009-1012, 19930401
  631. Randomized phase II trial of pemetrexed-cisplatin plus bevacizumab or thoracic radiotherapy followed by surgery for stage IIIA (N2) nonsquamous non-small cell lung cancer., J Thorac Cardiovasc Surg, 20211209
  632. Pathological high malignant grade is higher risk of recurrence in pN0M0 invasive lung adenocarcinoma, even with small invasive size., Thorac Cancer, 20211012
  633. Reply to "Lobe-Specific Lymph Node Dissection for Lung Cancer: Is It Still Feasible?" by Han-Yu Deng., Ann Surg Oncol, 20211009
  634. Risk of death due to other causes is lower among octogenarians with non-small cell lung cancer after wedge resection than lobectomy/segmentectomy., Jpn J Clin Oncol, 20211005
  635. Prognostic Impact of Mediastinal Lymph Node Dissection in Octogenarians With Lung Cancer: JACS1303., Clin Lung Cancer, 20210924
  636. ASO Author Reflections: Survival Outcomes between Patients with Hypermetabolic Non-small Cell Lung Cancer Undergoing Systematic and Lobe-Specific Mediastinal Lymph Node Dissection., Ann Surg Oncol, 20210903
  637. Clinicopathologic Features and Response to Therapy of NRG1 Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter Registry., J Clin Oncol, 20210901
  638. Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial., Lancet Respir Med, 20210826
  639. Parallel-Group Controlled Trial of Surgery Versus Chemoradiotherapy in Patients With Stage I Esophageal Squamous Cell Carcinoma., Gastroenterology, 20210810
  640. ASO Author Reflection: Position of the Complex Segmentectomy on Postoperative Pulmonary Function., Ann Surg Oncol, 20210723
  641. Postoperative Pulmonary Function After Complex Segmentectomy., Ann Surg Oncol, 20210722
  642. Neoadjuvant pemetrexed plus cisplatin followed by pleurectomy for malignant pleural mesothelioma., J Thorac Cardiovasc Surg, 20210717
  643. Ultrasonography Combined With Contrast-enhanced Ultrasonography Can Predict Lymphocyte-predominant Breast Cancer., Cancer Diagn Progn, 20210703
  644. Systematic Versus Lobe-Specific Mediastinal Lymphadenectomy for Hypermetabolic Lung Cancer., Ann Surg Oncol, 20210703
  645. Complete Response for Advanced Hepatocellular Carcinoma by Conversion Surgery Therapy Following a Good Response of Regorafenib Despite Rapid Progressive Disease with Sorafenib., Intern Med, 20210701
  646. Adjuvant Chemotherapy for High-risk Pathologic Stage I Non-Small Cell Lung Cancer., Ann Thorac Surg, 20210626
  647. Role of Soluble Receptor for Advanced Glycation End Products in Postoperative Fibrotic Lung Injury., Ann Thorac Surg, 20210615
  648. Identification of High-Risk of Recurrence in Clinical Stage I Non-Small Cell Lung Cancer., Front Oncol, 20210607
  649. Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer., BMC Pulm Med, 20210602
  650. Prognostic role of interstitial pneumonia with or without emphysema in patients with clinical stage I lung cancer., Jpn J Clin Oncol, 20210601
  651. The impact of pathological lymph node metastasis with lymphatic invasion on the survival of patients with clinically node-negative non-small cell lung cancer: A multicenter study., Lung Cancer, 20210529
  652. Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer., Breast Cancer, 20210528
  653. ASO Author Reflections: Is Wedge Resection Optimal for Octogenarians with Early-Stage Non-Small-Cell Lung Cancer Compared with Lobectomy/Segmentectomy?, Ann Surg Oncol, 20210523
  654. Clinical effect of the pathological axillary assessment method in breast cancer without clinical nodal metastasis., Breast Cancer, 20210519
  655. A risk model for prolonged air leak after lobectomy using the National Clinical Database in Japan., Surg Today, 20210517
  656. Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patients., Sci Rep, 20210512
  657. Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma., JTO Clin Res Rep, 20210429
  658. Segmentectomy for STAS positive lung adenocarcinoma., Ann Thorac Surg, 20210429
  659. Reply to Zhang et al., Eur J Cardiothorac Surg, 20210429
  660. Japanese Current Status of Curative-Intent Surgery for Malignant Pleural Mesothelioma., Ann Thorac Surg, 20210427
  661. Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non-small-cell Lung Cancer: SQUAT trial (WJOG 12119L)., Clin Lung Cancer, 20210427
  662. Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303., Ann Surg Oncol, 20210426
  663. Transition of Treatment for Ground Glass Opacity-Dominant Non-Small Cell Lung Cancer., Front Oncol, 20210415
  664. Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study)., Breast Cancer, 20210403
  665. Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study)., Breast Cancer, 28(5), 1023-1037, 20210403
  666. Prediction of the tumor response and survival based on computed tomography in esophageal squamous cell carcinoma after trimodality therapy., Surg Today, 20210402
  667. Prediction of the tumor response and survival based on computed tomography in esophageal squamous cell carcinoma after trimodality therapy., Surg Today, 20210402
  668. Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung., J Cancer Res Clin Oncol, 20210401
  669. CheckMate 577 Investigators.Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer, N Engl J Med, 20210401
  670. Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung., J Cancer Res Clin Oncol, 20210401
  671. Preoperative nivolumab to evaluate pathological response in patients with stage I non-small cell lung cancer: a study protocol of phase II trial (POTENTIAL)., BMJ Open, 20210317
  672. Breast cancer detection by dedicated breast positron emission tomography according to the World Health Organization classification of breast tumors., Eur J Surg Oncol, 20210303
  673. Surgical challenges in multimodal treatment of N2-stage IIIA non-small cell lung cancer., Jpn J Clin Oncol, 20210303
  674. Appropriate Extent of Lymphadenectomy in Segmentectomy: A Multicenter Study., Jpn J Clin Oncol, 20210303
  675. Bronchial mucosal ablation for bronchial stump closure in right pneumonectomy: a case report., J Med Case Rep, 20210218
  676. Certified thoracic surgeons in Japan: a national database survey on risk-adjusted mortality associated with lung resection., Surg Today, 20210130
  677. Performance of dedicated breast positron emission tomography in the detection of small and low-grade breast cancer., Breast Cancer Res Treat, 20210123
  678. A phase II study of cisplatin plus vinorelbine combined with atezolizumab as adjuvant therapy for completely resected non-small-cell lung cancer with EGFR mutation (West Japan Oncology Group 11719L/ADJUST study)., Ther Adv Med Oncol, 20210121
  679. Salvage surgery for non-small cell lung cancer after tyrosine kinase inhibitor treatment., Lung Cancer, 20210110
  680. Long-term results of definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma., J Radiat Res, 20210101
  681. Recent advances and future perspectives in adjuvant and neoadjuvant immunotherapies for lung cancer., Jpn J Clin Oncol, 20210101
  682. Recent advances and future perspectives in adjuvant and neoadjuvant immunotherapies for lung cancer., Jpn J Clin Oncol, 20210101
  683. Long-term results of definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma., J Radiat Res, 20210101
  684. Clinical Efficacy and Safety of Nivolumab in Japanese Patients With Malignant Pleural Mesothelioma: 3-Year Results of the MERIT Study., JTO Clin Res Rep, 20201229
  685. Prediction of Unexpected N2 Disease Associated With Clinical T1-2N0-1M0 Non-Small-Cell Lung Cancer., Clin Lung Cancer, 20201227
  686. Utility of Newly Proposed Grading System From International Association for the Study of Lung Cancer for Invasive Lung Adenocarcinoma., JTO Clin Res Rep, 20201126
  687. Salvage Surgery for Non-Small Cell Lung Cancer After Definitive Radiotherapy., Ann Thorac Surg, 20201126
  688. Salvage surgery for non-small-cell lung cancer after definitive radiotherapy., Ann Thorac Surg, 20201126
  689. Surgical Procedure Selection for Stage I Lung Cancer: Complex Segmentectomy versus Wedge Resection., Clin Lung Cancer, 20201117
  690. Surgical Procedure Selection for Stage I Lung Cancer: Complex Segmentectomy versus Wedge Resection., Clin Lung Cancer., 20201117
  691. Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)., Esophagus, 20201110
  692. Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer., Support Care Cancer, 20201104
  693. Segmentectomy vs Lobectomy for Clinical Stage IA Lung Adenocarcinoma With Spread Through Air Spaces., Ann Thorac Surg, 20201102
  694. Comparison of cancer control between segmentectomy and wedge resection in patients with clinical stage IA non-small cell lung cancer., J Thorac Cardiovasc Surg, 20201022
  695. Prediction of Acute Exacerbation of Interstitial Pneumonia Using Visual Evaluation of PET., Ann Thorac Surg, 20201012
  696. ASO Author Reflections: Usefulness of Visual Evaluation of PET in Predicting Prognosis after Lung Resection for Early-Stage Lung Adenocarcinoma and Selecting Candidates for Sublobar Resection., Ann Surg Oncol, 20200923
  697. Patient Selection of Sublobar Resection Using Visual Evaluation of Positron-Emission Tomography (PET) for Early-Stage Lung Adenocarcinoma., Ann Surg Oncol, 20200918
  698. Distribution of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma After Trimodal Therapy., Ann Surg Oncol, 20200903
  699. Oncologic Outcomes of Complex Segmentectomy: A Multicenter Propensity Score-Matched Analysis., Ann Thorac Surg, 20200812
  700. Commentary: Aspects of epidermal growth factor receptor status: Prognostic factor versus predictive factor., J Thorac Cardiovasc Surg, 20200803
  701. Long-Term Outcomes After Sublobar Resection Versus Lobectomy in Patients With Clinical Stage IA Lung Adenocarcinoma Meeting the Node-Negative Criteria Defined by High-Resolution Computed Tomography and [18F]-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography., Clin Lung Cancer, 20200619
  702. Novel technique for identification of the pulmonary intersegmental plane using manual jet ventilation during pulmonary segmentectomy., Wideochir Inne Tech Maloinwazyjne, 20200601
  703. Differences in immune response to anesthetics used for day surgery versus hospitalization surgery for breast cancer patients., Clinical and translational medicine, 201709
  704. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease., The Journal of thoracic and cardiovascular surgery, 154(3), 1089-1096, 201709
  705. Gene expression profiling of idiopathic interstitial pneumonias (IIPs): identification of potential diagnostic markers and therapeutic targets., BMC medical genetics, 201708
  706. Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection?, General thoracic and cardiovascular surgery, 201706

Publications such as books

  1. 2012, Illustrated Anatomical Segmentectomy for Lung Cancer, Nomori,Hiroaki Okada,Morihito

External Funds

Acceptance Results of Competitive Funds

  1. Practical Research for Innovative Cancer Control, 2023//4//1, 2024//3//3
  2. Practical Research for Innovative Cancer Control, 2023//4//1, 2024//3//3
  3. Practical Research for Innovative Cancer Control, 2023//4//1, 2024//3//3
  4. Practical Research for Innovative Cancer Control, 2022//0/4/, 2023//0/3/
  5. Practical Research for Innovative Cancer Control, 2022//0/4/, 2023//0/3/
  6. Practical Research for Innovative Cancer Control, 2022//0/4/, 2023//0/3/
  7. Practical Research for Innovative Cancer Control, 2022//0/4/, 2023//0/3/
  8. Practical Research for Innovative Cancer Control, 2021/04/01, 2022/03/31
  9. Practical Research for Innovative Cancer Control, 2021/04/01, 2022/03/31
  10. Practical Research for Innovative Cancer Control, 2021/04/01, 2022/03/31
  11. Practical Research for Innovative Cancer Control, 2021/04/01, 2022/03/31
  12. Practical Research for Innovative Cancer Control, 2015/04/01, 2016/03/31
  13. KAKENHI, 2014, 2015
  14. KAKENHI, Application of pseudopodia proteomics using excimer laser ablation for investigation of lung cancer invasion, 2012, 2013
  15. KAKENHI, New chemoradiotherapy for esophageal cancer targeting DNA repair proteins, 2010, 2012
  16. KAKENHI, Comprehensive analysis of novel genes regulating the malignant transformation in small-sized lung adenocarcinoma, 2009, 2011
  17. Health and Labour Sciences Research Grants, 2014/05/01, 2015/03/31
  18. KAKENHI, 2013, 2015
  19. KAKENHI, 2013, 2015
  20. KAKENHI, 2012, 2014
  21. KAKENHI, 2012, 2014
  22. KAKENHI, Analysis of tumor hypoxia in lung cancer using real time mass spectrometry, 2010, 2012
  23. KAKENHI, Development of an ultra-sensitive detection of EGFR gene mutations by single-cell level video-mass-scope, 2010, 2011
  24. KAKENHI, 2015, 2018
  25. KAKENHI, 2015, 2018
  26. Practical Research for Innovative Cancer Control , 2016/04/01, 2017/03/31
  27. Practical Research for Innovative Cancer Control , 2017/04/01, 2018/03/31
  28. Practical Research for Innovative Cancer Control , 2017/04/01, 2018/03/31
  29. Practical Research for Innovative Cancer Control , 2018/04/01, 2019/03/31
  30. Practical Research for Innovative Cancer Control , 2018/04/01, 2019/03/31
  31. KAKENHI(Grant-in-Aid for Challenging Research (Exploratory)), 2018, 2019
  32. Practical Research for Innovative Cancer Control , 2019/04/01, 2020/03/31
  33. Practical Research for Innovative Cancer Control , 2019/04/01, 2020/03/31
  34. Practical Research for Innovative Cancer Control, 2020/04/01, 2021/03/31
  35. Practical Research for Innovative Cancer Control, 2020/04/01, 2021/03/31
  36. Practical Research for Innovative Cancer Control, 2020/04/01, 2021/03/31
  37. Practical Research for Innovative Cancer Control, 2020/04/01, 2021/03/31

Social Activities

History as Peer Reviews of Academic Papers

  1. Journal of Clinical Oncology
  2. Journal of Thoracic and Cardiovascular Surgery
  3. Chest
  4. Annals of Thoracic Surgery
  5. European Journal of Cardiothoracic Surgery
  6. Lung Cancer
  7. Journal of Thoracic Oncology
  8. Surgery Today
  9. Cancer Science
  10. Japanese Journal of Clinical Oncology, Editor
  11. General Thoracic and Cardiovascular Surgery, Editor